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Abstract
Although carbohydrates are known to participate in many important
processes including inflammation, cancer metastasis and pathogenic infection, their
functional roles are only beginning to be understood on a molecular level.  The challenge
is that carbohydrates and glycoproteins are inherently difficult to study.  Unlike DNA and
proteins, carbohydrate structures are not template-encoded, and the modifications are
challenging to detect in vivo and manipulate for structure-function analyses.  As such,
new tools are needed to complement the traditional biochemical and genetic approaches
in order to advance our understanding of carbohydrates and their physiological roles.
Here, we seek to understand the roles of carbohydrates in regulating the structure and
function of proteins in the brain.  Our major focus will be on two carbohydrate
modifications that play important roles in neuronal communication, development and
memory storage: fucosylation (Part I) and chondroitin sulfate glycosaminoglycan
modifications (Part II).
In Part I, we describe our progress in elucidating the molecular mechanisms by
which fucosyl saccharides regulate neuronal communication in the brain.  Information
flow in the brain is regulated by synapses, which are specialized sites of contact between
neurons.  Synaptic connections involve numerous molecular recognition events among
proteins, carbohydrates, and small molecules.  One of the molecules enriched at the
synapse is the sugar L-fucose.  Previous studies have suggested that fucoseα(1-
2)galactose (Fucα(1-2)Gal) saccharides play essential roles in learning and memory.  For
instance, preventing formation of Fucα(1-2)Gal linkages has been shown to cause
reversible amnesia in animals.  Despite these intriguing observations, proteins that
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express the Fucα(1-2)Gal epitope (glycoproteins) or proteins that bind this epitope
(lectins) have not been identified.  Through the use of several chemical probes, we have
established that Fucα(1-2)Gal associated proteins participate in a novel carbohydrate-
mediated pathway for regulating neuronal growth.  Additionally, we have found that
Fucα(1-2)Gal glycoproteins are prevalent in the developing brain and that synapsin Ia/Ib
are the major Fucα(1-2)Gal glycoproteins in the adult brain.  In our attempts to identify
Fucα(1-2)Gal lectins, we have established that multivalent polymers enhance our ability
to capture and characterize such proteins.
In Part II, we describe our efforts toward understanding the role of chondroitin
sulfate glycosaminoglycans in neuronal development.  Chondroitin sulfate (CS)
glycosaminoglycans are linear, sulfated polysaccharides implicated in cell division,
neuronal growth, and spinal cord injury.  The structural complexity and heterogeneity of
CS has hampered efforts to understand its precise biological roles.  Although they exist as
a heterogeneous mix in nature, it is thought that CS activity is dictated by a sulfation code
where distinct sulfation sequences are spatially and temporally regulated and direct the
biological activity of CS glycosaminoglycans.  We have developed a chemical approach
to evaluate the structure-activity relationship of CS as it effects neuronal growth. We
generated the first synthetic library of well-defined CS oligosaccharides containing
various sulfation sequences and have demonstrated that the CS-E sulfation sequence is a
stimulatory motif that promotes the growth of several neuron types.  Moreover, we
determined that CS-E mediated stimulation of neurite outgrowth was facilitated by
activation of midkine/PTPζ and BDNF/TrkB signaling pathways.
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1Part I—Chapter 1: Fucosylation in the Brain
Carbohydrates in cellular communication
The cell surface is a fluid, dynamic structure composed of many different
biomolecules, including proteins, lipids, and carbohydrates.  Most often, carbohydrates
are found on the cellular membrane covalently bound to lipids and proteins, where they
form glycolipids and glycoproteins, respectively.  These membrane-bound carbohydrates
serve as markers that distinguish individual cells and are crucial elements in cell-cell
recognition and communication.  Many glycoproteins are known to be involved in
numerous biological processes including cell differentiation, neuronal growth,
interneuronal recognition, and signal transduction.1, 2  In the brain, about 80% of
glycoproteins are found in the microsomal fraction and in synaptic membranes.3
The reorganization of synaptic membranes (synaptic remodeling) allows for the
formation of memory traces and involves changes in the synthesis of glycoproteins as
well as posttranslational modifications to existing glycoproteins.4  This synaptic
remodeling is thought to underlie information processing in the brain and leads to
memory formation.  One of the leading models for how memory traces are
mechanistically formed in the brain is long-term potentiation (LTP), a process where
high-frequency stimulation of a nerve cell causes an abrupt and sustained increase in the
efficiency of synaptic transmission of the signal.4  LTP has been found to occur in both
vertebrates and invertebrates in a variety of neural systems, ranging from the mammalian
peripheral nervous system to the arthropod neuromuscular junction to subcortical
mammalian nuclei, such as the amygdala.5
2Changes in neuronal morphology have been directly associated with LTP in
various systems.  Inducing LTP in cultured rat hippocampal slices caused new spines to
appear on post-synaptic dendrites, whereas no significant spine growth was found in
regions where LTP was blocked.6  Similar results were seen in hippocampal slices from
spatially trained rats, where a significant increase in dendritic spine density was observed
in trained rats compared to nontrained rats.7  Such synaptic remodeling could involve
glycosylation of synaptic proteins, as supported by the presence of protein glycosylation
machinery in dendrites.8  Interestingly, the presence of glycosylation machinery in
dendrites suggests that the synthesis of glycoproteins at the synapse may be dynamically
regulated.  Moreover, protein glycosylation has been shown to be necessary for
maintaining hippocampal LTP.  Treating hippocampal slices with different protein
glycosylation inhibitors (tunicamycin, brefeldin A, swainsonine) during induction of LTP
prevented maintenance of LTP and caused postsynaptic potentials to return to baseline
levels within 100 minutes after induction of LTP.9  However, postsynaptic potentials
from control slices remained elevated for more than 200 minutes following induction of
LTP.9  These findings provide a direct link between learning, LTP, synaptic remodeling,
and protein glycosylation.
Evidence for the importance of fucose α (1-2) galactose glycoproteins in the
mammalian brain
The formation of synaptic connections and synaptic remodeling involves the
recognition of different molecules present at the membrane, including various proteins,
lipids, carbohydrates, and other small molecules.  We are particularly interested in the
3O
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Figure 1.1. The monosaccharide L-fucose
sugar L-fucose (Figure 1.1), one of the small molecules enriched in the synaptosomal
fraction.10
L-Fucose (Fuc) is one of the 9 standard carbohydrate building blocks commonly
found in mammals, and fucose-containing oligosaccharides play important roles in many
biological processes, including blood transfusion reactions, host-microbe interactions,
and cancer pathogenesis.11  Fucose is appended to various biomolecules by
fucosyltransferases, of which thirteen have been identified in the human genome.11  All
currently identified fucosyltransferases utilize guanosine diphosphatyl-fucose (GDP-
fucose) as the monosaccharide donor.  In mammalian cells, two pathways exist for the
synthesis of GDP-fucose, the de novo pathway and the salvage pathway (Figure 1.2).
The de novo pathway converts GDP-mannose to GDP-fucose via three enzymatic
reactions carried out by two enzymes.  First, GDP-mannose-4,6-dehydratase (GMD)
converts GDP-mannose to GDP-4-keto-6-deoxymannose through oxidation of the
hydroxyl group at C-4 of the mannose ring and reduction of the hydroxyl group at C-6.
Next, the dual functional epimerase-reductase enzyme known as the FX protein converts
GDP-4-keto-6-deoxymannose to GDP-fucose. In the salvage pathway, GDP-fucose is
synthesized from free fucose via a two-step process.  In the first step, free fucose derived
from extracellular or lysosomal sources is transported into the cytosol and converted to
fucose-1-phosphate via fucose kinase.  Next, GDP-fucose pyrophosphorylase catalyzes
the reversible condensation of fucose-1-phosphate with GTP to form GDP-fucose.  All
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Figure 1.2.  In mammalian cells, the biosynthesis of GDP-fucose occurs through two distinct pathways.
The de novo pathway converts GDP-mannose to GDP-fucose via three enzymatic reactions carried out
by two proteins, GMD and the FX protein. The salvage pathway utilizes free fucose found in the
cytosol to synthesize GDP-fucose using the enzymes fucose kinase and GDP-fucose
pyrophosphorylase.  GDP-fucose generated by either pathway is transported into the Golgi lumen to
become available to the fucosyltransferases.
GDP-fucose, synthesized from either pathway, must then enter the Golgi apparatus to be
used for fucosylation reactions by the fucosyltranferases.
In the brain, L-Fuc is usually found as the terminal residue on carbohydrate chains
attached to proteins via N - or O-linkages to asparagine or serine/threonine residues,
respectively.12, 13  Frequently, L-Fuc is attached to the C-3 and C-6 positions of N-
acetylglucosamine (GlcNAc) or to the C-2 position of galactose (Gal) (Figure 1.3).12
Several studies support the idea that oligosaccharides containing terminal fucose α(1-2)
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Figure 1.4. Incorporation of 2-deoxy-D-Galactose (2-dGal) inhibits formation of Fucα(1-2)Gal
linkages. 2-dGal is missing the hydroxyl group at the C-2 position (red arrow) and thus prevents the
incorporation of fucose into carbohydrate chains.
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Figure 1.3.  Common fucose-galactose linkages found on the terminal ends of carbohydrate chains
galactose (Fucα(1-2)Gal) moieties contribute to information storage and processing in
the brain.
The importance of Fucα (1-2)Gal is supported by behavioral and
electrophysiological studies using the unnatural sugar analog 2-deoxy-D-galactose (2-
dGal).  In these studies, the sugar analog 2-dGal competes with Gal for incorporation into
carbohydrate chains.14  Once inserted, 2-dGal inhibits the formation of a specific 1-2
glycosidic linkage with fucose because it lacks the hydroxyl group at the C-2 position
(Figure 1.4).
Fucose incorporation into hippocampal glycoproteins was found to be
significantly reduced in trained rats injected with 2-dGal compared to saline-treated
rats.15, 16  Furthermore, treating rats with 2-dGal either 30 minutes before or 15 minutes
6after retrieval testing caused amnesia in a passive avoidance response.17  Similar
experiments performed in trained chicks also resulted in decreased fucose incorporation
and amnesic effects in animals treated with 2-dGal.18, 19  In electrophysiological studies,
hippocampal LTP maintenance was also suppressed upon treatment with 2-dGal.20  These
studies underscore the importance of Fucα(1-2)Gal glycoproteins in long-term memory
formation.
Although many studies have looked at the amnesic effects of 2-dGal in the brain,
studies have yet to examine the impact of 2-dGal on synaptic remodeling or neuronal
structure.  However, related small molecules have been shown to elicit varying effects in
cell culture.  Incorporation of the sugar analog 2-deoxy-2-fluoro-D-galactose in cultured
rat hepatocytes inhibited N-glycosylation of membrane proteins.21, 22  However, addition
of the analog 2-deoxy-2-fluoro-D-glucose only partially inhibited N-glycosylation.22
Furthermore, neither analog affected O-glycosylation.
Additional support for the importance of fucose-expressing glycoproteins in
learning and memory can be found in studies examining the levels of fucose
incorporation following learning tasks.  When incorporation of [14C]-labeled fucose was
monitored in trained chicks, a linear increase of fucose could be seen in forebrain slices
for up to 3 hours after training.3  Furthermore, a 26% increase in tritium-labeled fucose
24 hours following learning in trained chicks, as compared to nontrained chicks, was
observed in a separate study.23  Collectively, these findings support the view that
glycoproteins expressing the Fucα(1-2)Gal epitope play a critical role in neuronal
communication.
7It is interesting to note that glycoproteins present at synapses have been
previously implicated in cellular recognition and adhesion steps during synaptic
development.  A well-studied example is the neural cell adhesion molecule (NCAM), a
member of the immunoglobulin superfamily that is glycosylated with polysialic acid
(PSA) residues.  NCAM is crucial in the development and regeneration of the nervous
system and is also involved in synaptogenesis.24, 25  Interestingly, the PSA residues
present on NCAM greatly affect these functions.  Enzymatic removal of PSA with
endoneuraminidase (endo N) inhibited LTP in the hippocampus and disrupted neuron
migration and axon outgrowth.26 -- 29  Polysialylated NCAM also helps maintain
membrane fluidity and neural plasticity by increasing intermembrane repulsion and
inhibiting cellular adhesion.30
Evidence for the existence of Fucα(1-2)Gal lectins in the mammalian brain
In addition to the role of fucose-containing glycoproteins, there is evidence that
proteins which specifically recognize fucose may also be involved in regulating neuronal
communication.  The importance of lectins (proteins that recognize carbohydrates) that
specifically recognize the Fucα(1-2)Gal moiety in memory formation has been
demonstrated in several behavioral studies using an antibody specific to the Fucα(1-
2)Gal epitope.
The monoclonal antibody A46-B/B10, which recognizes the trisaccharide
Fucα(1-2)Galβ(1-4)GlcNAc31 (Figure 1.5), was injected intrahippocampally to rats
trained on a brightness discrimination task.  Administration of the antibody both before
and after training did not interfere with learning but drastically reduced the retention of
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Figure 1.5. The trisaccharide Fucα(1-2)Galβ(1-4)GlcNAc recognized by antibody A46-B/B10
the task in relearning sessions, whereas an antibody selective for other trisaccharides had
no amnesic effect.32  Although the potential molecular mechanism(s) by which the
antibody causes amnesia has not been elucidated, one potential explanation is that the
antibody prevents the interaction between Fucα(1-2)Gal-containing glycoproteins and
lectins.  These studies support the notion that Fucα(1-2)Gal lectins may be involved in
modulating neuronal communication.
Studies using free fucosyl saccharides provide further evidence for the importance
of Fucα(1-2)Gal lectins in the brain.  Several reports have shown that free fucosyl
saccharides enhance memory retention and LTP.  For instance, rats injected with L-Fuc
or the trisaccahride L-Fucα (1-2)Galβ(1-4)Glucose (2’-Fucosyllactose) exhibited
prolonged, enhanced potentiation following induction of LTP compared to control
animals injected with saline or lactose.33  Higher potentiation following LTP induction
was also observed in rat hippocampal slices incubated with L -Fuc and 2’-
Fucosyllactose.34  Importantly, the observed effects were stereo- and regiospecific as
neither D-fucose or 3’-Fucosyllactose showed any effect on LTP or memory
consolidation.34  While these effects may also be due in part to fucosylation of
9glycoproteins, another potential explanation is that these fucosyl saccharides could be
interacting with specific Fucα(1-2)Gal lectins on the cell surface to promote LTP.
The binding of lectins to specific carbohydrate motifs is well precedented in
mediating cellular recognition events, including leukocyte adhesion, microbial
phagocytosis, and neuronal outgrowth.35 -- 37  One well-studied example is the galectin
family of lectins, which specifically recognize galactose-containing oligosaccharides.
Galectins are found on both the cell surface and the extracellular matrix, as well as in the
cytoplasm and nucleus, and are involved in cell adhesion, cell growth, and apoptosis.38
Notably, galectin-3 mediates cell adhesion in a carbohydrate-dependent manner, as
treatment of cells with either endo-β-galactosidase (a protein that cleaves the galactose
moieties from the protein) or a polyvalent carrier of terminal β-galactosides inhibited
adhesion.39
Proposed mechanisms of Fucα(1-2)Gal action
As detailed in the above studies, L-Fuc and, in particular, the Fucα(1-2)Gal
saccharide appear to be critical components for long-term information storage.  Despite
the overwhelming evidence implicating the Fucα(1-2)Gal epitope in memory formation,
relatively little is known about the proteins that display (glycoproteins) or bind (lectins)
this epitope.  One research group has reported the identification of several proteins to be
Fucα(1-2)Gal glycoproteins.40  However, the existence of a Fucα(1-2)Gal epitope on
these proteins was not rigorously proven and was only shown through antibody binding,
which can be somewhat promiscuous.  Additionally, another group has reported the
fucose-mediated binding of the proteoglycan versican to the adhesion protein tenascin-R.
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Importantly, only the C-type lectin domain of versican, expressed as a recombinant
protein, was shown to bind to insolubilized fucose.41  Aside from these two reports, no
other Fucα(1-2)Gal glycoproteins or lectins have been identified.  Moreover, the
functional significance of the Fucα(1-2)Gal epitope has not yet been investigated.
Based on literature findings and our own results, we have developed three
working models to explain the role of fucosyl saccharides in modulating neuronal
communication.  In the first model, we propose that the Fucα(1-2)Gal epitope functions
as a “recognition element” to mediate protein-protein interactions at the cell surface
(Mechanism A, Figure 1.6).  In this model, specific molecular recognition between
Fucα(1-2)Gal glycoproteins and lectins would be expected to trigger intracellular
signaling cascades that modulate neuronal communication.  In the second model, we
propose that the Fucα(1-2)Gal epitope may function as a “targeting element” to regulate
the folding, function and/or trafficking of Fucα(1-2)Gal glycoproteins to the synapse
(Mechanism B, Figure 1.6).  By directing glycoproteins to the synapse, the Fucα(1-2)Gal
epitope may position the glycoproteins to perform essential functions, as well as help
recruit proteins to the synapse during cell communication events.  Alternatively, it is
possible that fucosyl glycoproteins may act intracellularly to modulate proteins and
signaling pathways involved in synaptic plasticity (Mechanism C, Figure 1.6).
Given the complexity of the brain, it is possible that these three mechanisms are
operating in parallel to mediate neuronal communication.  Regardless of which model is
correct, it is clear that identification of Fucα(1-2)Gal lectins and glycoproteins is
necessary to understand the potential role of fucosyl saccharides in the formation and
strengthening of synaptic connections.  Furthermore, the discovery of new lectins and
11
Figure 1.6. Proposed mechanisms by which the Fucα(1-2)Gal epitope acts in neurons.  Fucα(1-2)Gal
saccharides (F) may function as recognition elements to mediate protein-protein interactions between
Fucα(1-2)Gal lectins and glycoproteins (mechanism A) or as targeting elements to increase the
concentration of fucose at the synapse (mechanism B). Additionally, Fucα(1-2)Gal proteins may
operate intracellularly to modulate proteins at the synapse.
glycoproteins will enable a molecular-level understanding of the role of fucosyl
saccharides on neuronal communication and provide new insights into cell
communication and synaptic plasticity in the brain.
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Chapter 2: Fucose α(1-2) Galactose Carbohydrates Regulate Neuronal Growth∗†
Background
Carbohydrates play important roles in numerous biological processes and are key
modulators of molecular and cellular recognition.  The diverse chemical structures of
carbohydrates encode vast amounts of information and serve as critical determinants of
protein folding, trafficking, and stability.1  Carbohydrates are highly abundant in the brain
and are involved in various neural functions including learning and memory, brain
development, and spinal cord injury.2 -- 4  Despite their importance in neurobiology, the
precise molecular mechanisms by which carbohydrates influence these processes in the
brain are not well understood.
In the brain, information flow from one cell to another is regulated by synapses,
which are specialized sites of contact between neurons.  Not surprisingly, about 80% of
glycoproteins are found in the microsomal fraction and in synaptic membranes.5  One of
the molecules enriched at the synapse is the sugar L-fucose.6  L-Fucose primarily exists as
a terminal residue on N- or O-linked glycoproteins and is frequently attached to the C-3
and C-6 position of N-acetylglucosamine or the C-2 position of galactose.7  Interestingly,
the fucose α(1-2) galactose (Fucα(1-2)Gal) linkage has been implicated in cognitive
processes such as learning and memory.
                                                 
∗ Synthesis of fucose α(1-2) galactose probe 1 was done by Dr. Lori W. Lee, a former graduate student in
the Hsieh-Wilson laboratory, and Dr. Stacey A. Kalovidouris, a former postdoctoral scholar in the Hsieh-
Wilson laboratory. Treatment of neuronal cultures with multivalent polymers and known fucose lectins
were done in collaboration with Dr. Kalovidouris.
† Portions of this chapter were taken from S.A. Kalovidouris et al. (2005) J. Am. Chem. Soc. 127, 1340 –
1341.
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Several lines of evidence suggest that Fucα(1-2)Gal carbohydrates play essential
roles in modulating neuronal connections important for learning and memory.  For
instance, blocking the formation of Fucα(1-2)Gal linkages on glycan chains using 2-
deoxy-D-galactose (2-dGal) causes reversible amnesia in animals and interferes with the
maintenance of long-term potentiation (LTP).8 -- 11  Since 2-dGal specifically inhibits the
incorporation of [14C]-radiolabeled fucose into glycoproteins at the synapse8, it is possible
that Fucα(1-2)Gal glycoproteins contribute to memory storage.  Additionally, injection of
a monoclonal antibody selective for Fucα(1-2)Gal also impairs memory formation in
animals12, 13, presumably by blocking the Fucα(1-2)Gal epitope.  Furthermore, both task-
specific learning and LTP have been shown to increase fucosylation of proteins at the
synapse and addition of L-fucose or 2’-fucosyllactose was found to enhance LTP.5, 14 -- 16
Despite these intriguing observations, relatively little is known about the proteins
that express the Fucα(1-2)Gal epitope (glycoproteins) or those proteins that bind this
epitope (lectins).  Furthermore, no Fucα(1-2)Gal-associated proteins have been identified
from the brain.  We therefore sought to establish the existence of Fucα(1-2)Gal lectins
and glycoproteins in the brain.  Through the use of chemical and biochemical tools, we
have demonstrated that Fucα(1-2)Gal and its associated proteins promote the growth of
hippocampal neurons and identify a novel, carbohydrate-mediated pathway for regulating
neuronal growth and morphology.
Fucα(1-2)Gal lectins exist in neurons
The overall goal of our research project is to understand how fucosyl saccharides
are involved in cell-cell recognition in the brain and to determine how these
18
Figure 2.1. Fucα(1-2)Gal-biotin probe 1 was designed to mimic endogenous glycoproteins.  The two
main structural elements are a Fucα(1-2)Gal moiety (red) for protein recognition and a biotin moiety
(green) for fluorescent labeling.
carbohydrates impact different processes such as learning and memory.  Toward this end,
we developed a chemical probe for detecting Fucα(1-2)Gal lectins in neurons.  The small
molecule probe was synthesized by Dr. Lori W. Lee and Dr. Stacey A. Kalovidouris and
was made to mimic endogenous glycoproteins containing Fucα(1-2)Gal linkages (Figure
2.1).17  This probe, 1, has two key structural elements: (1) the Fucα(1-2)Gal moiety and
(2) a biotin moiety.
The Fucα(1-2)Gal disaccharide was selected as the recognition element to
conclusively demonstrate the importance of the Fucα(1-2)Gal linkage.  We decided
against using a trisaccharide, as previous research has failed to provide conclusive
evidence about the identity or importance of the third sugar.  Moreover, L-fucose or 2’-
fucosyllactose can stimulate memory formation with approximately equal efficacy,
suggesting that Fucα(1-2)Gal may be sufficient for interaction with target lectins.  The
biotin moiety was included to enable examination of the cellular localization of Fucα(1-
2)Gal lectins by fluorescence microscopy.  Biotin binds specifically and with high
affinity to streptavidin, and a variety of streptavidin-dye conjugates are commercially
available for fluorescence staining of cells.
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With Fucα(1-2)Gal probe 1 in hand, we tested whether lectins specific for the
fucose disaccharide are present in neurons.  Using protocols similar to those of Goslin,
Asmussen and Banker18, hippocampal cultures were prepared from embryonic-day 18
(E18) rats and were maintained in culture for at least two weeks.  Over the course of two
weeks, the cells develop neurites and axons (day 1 – 2), dendrites (day 4 – 5) and,
eventually, elaborate networks of neuronal processes and synapses (day > 7).  During
each stage of development, neurons can be fixed and treated with small molecules or
antibodies for specific proteins or carbohydrates.  Thus, the expression and subcellular
localization of those carbohydrates, lectins, and glycoproteins of interest can be
monitored by fluorescence microscopy.  This allowed us to study how the expression and
distribution of Fucα(1-2)Gal lectins may change with neuronal development or external
stimuli.
Fucα(1-2)Gal probe 1 was incubated for 1 hour with neurons that had been
cultured for 14 days in vitro (DIV) and then fixed.  Following application of probe 1, the
neurons were washed and incubated with streptavidin conjugated to AlexaFluor 488 dye
(Molecular Probes) and the Fucα(1-2)Gal probe was detected using confocal
fluorescence microscopy.  As shown in Figure 2.2, probe 1 binds specifically to neurons
and labels the cell body, neuronal processes, and possibly synapses.  Several control
experiments were conducted to confirm that the observed fluorescence was due to
specific recognition of the Fucα(1-2)Gal probe.  Upon optimization of the blocking,
incubation, and wash steps, we were able to identify conditions where low background
staining was obtained, proving that the streptavidin dye conjugate was not simply
staining the neurons in the absence of the probe (Figure 2.2B).  Second, we confirmed
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Probe 1 Biotin
Figure 2.3. Fucα(1-2)Gal probe 1 binds to hippocampal neurons. Neurons were cultured for 23 DIV and
then treated with 3 mM of (A) probe 1 or (B) biotin in the presence of 10 µM PAO.  Scale bars, 45 µm
that the results were not attributable to the biotin portion of the molecule by incubating
neurons with D-biotin alone.  Once again, we obtained no significant background
fluorescence (Figure 2.2C).  Thus, our experimental data provide strong evidence that
Fucα(1-2)Gal lectins exist in hippocampal neurons.
To prevent intracellular uptake of the compounds, neurons were co-incubated
with the endocytosis inhibitor phenyl arsine oxide (PAO).19  After 23 DIV, hippocampal
neurons were treated with 10 µm PAO and either probe 1 or biotin.  After 1 hour, neurons
were washed, fixed, and stained with streptavidin-dye conjugate and examined by
fluorescence microscopy.  Again, we saw that probe 1 specifically labels the cell body
and neurite processes (Figure 2.3).17
A B C
Probe 1 Streptavidin Biotin
Figure 2.2. Fucα(1-2)Gal probe 1 binds to the cell surface of hippocampal neurons. A) Probe 1 (10
mM) binds selectively to neurons. B) Incubation of neurons with streptavidin dye conjugate produces
no background signal. C) Incubation of neurons with biotin (10 mM) also produces no background
signal. Scale bars, 20 µm
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Figure 2.4. Lipid extraction does not alter labeling with Fucα (1-2)Gal probe 1. Neurons were
delipidated with MeOH/CHCl3 prior to labeling with 3 mM of (A) probe 1 or (B) biotin in the presence
of 10 µM PAO.  Scale bars, 45 µm
To confirm that probe 1 was binding specifically to proteins rather than
interacting with the membrane lipids, neurons were delipidated following the protocol of
Yavin and Yavin.20  Briefly, after 23 DIV, cells were rinsed with PBS and exposed to a
methanol/chloroform mixture (MeOH/CHCl3; 1/2 by volume) for 15 minutes at –80 °C.
This procedure fixes the cells to the glass coverslip and extracts cellular lipids.  After
removing the MeOH/CHCl3 mixture, neurons were treated with PAO and either probe 1
or biotin.  Lipid extraction of cellular membranes prior to treatment with probe 1 did not
diminish the labeling (Figure 2.4),17 consistent with a carbohydrate-protein interaction.
After determining that the Fucα(1-2)Gal probe recognized proteins in cultured
neurons, we conducted several experiments to determine the subcellular localization of
the Fucα(1-2)Gal lectins that were being detected.  First, we simultaneously incubated
neurons with probe 1 and an antibody to tau protein.  Tau is a microtubule-binding
protein that is found in cell bodies, axons, and dendrites.21  After incubating with the
streptavidin-dye conjugate and the appropriate secondary antibody for the tau antibody,
neurons were visualized with a confocal laser microscope equipped with 488 nm and 546
Probe 1 Biotin
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A B C
Probe 1 Anti-tau Overlay
Figure 2.5. Costaining of neurons with Fucα(1-2)Gal probe 1 and an anti-tau antibody.  A) Probe 1
staining (green).  B) Tau antibody labels axons, dendrites, and cell bodies.  C) Overlay of probe 1 and
tau labeling (yellow indicates colocalization) shows that Fucα(1-2)Gal staining is distributed on the cell
body and along dendrites and axons. Scale bars, 25 µm
A B C
Probe 1 Anti-MAP2 Overlay
Figure 2.6.  Costaining of neurons with Fucα(1-2)Gal probe 1 and a MAP2 antibody.  A) Probe 1
staining (green).  B) MAP2 labeling (red) shows dendrites and cell body.  C) Overlay of probe 1 and
MAP2 labeling (yellow indicates colocalization) shows that Fucα(1-2)Gal staining is distributed on the
cell body, along dendrites and axons. Scale bars, 25 µm
nm laser lines (Figure 2.5).  Again we see that probe 1 (green) binds to the cell surface
and along both dendrites and axons and overlaps almost completely with the tau labeling
(red).
Second, we concurrently stained neurons with Fucα(1-2)Gal probe 1 and anti-
MAP2 antibodies.  MAP2 is a selective marker for dendritic processes.22  In Figure 2.6,
we see that probe 1 (green) clearly binds to dendrites labeled with the MAP2 antibody
(red).  We also see binding of Fucα(1-2)Gal probe 1 to axons and on the cell surface
(Figure 2.6A).
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Probe 1 Anti-synapsin Overlay
Figure 2.7.  Costaining of neurons with Fucα(1-2)Gal probe 1 and an anti-synapsin antibody.  A) Probe
1 staining (green).  B) Synapsin antibody (red) labels presynaptic terminals.  C) Overlay of probe 1 and
synapsin labeling (yellow indicates colocalization) shows that Fucα(1-2)Gal staining does not
completely overlap with synapsin staining. Scale bars, 25 µm
Next, we sequentially stained neurons first with Fucα(1-2)Gal probe 1, followed
by an antibody specific for synapsin.  Synapsin is a marker for synapses and is found in
pre-synaptic terminals.23  As shown in Figure 2.7, Fucα(1-2)Gal binding (green) does not
completely overlap with synapsin labeling (red).  Interestingly, many of the puncta for
the probe and the antibody are adjacent to one another, suggesting a post-synaptic
localization for the Fucα(1-2)Gal-binding proteins.
Fucα(1-2)Gal glycoproteins are present in neurons
The presence of potential lectins specific for Fucα(1-2)Gal implies the existence
of glycoproteins covalently modified by the disaccharide epitope.  To determine whether
such glycoproteins are present in neurons, we treated cells with Ulex europeaus
agglutinin I lectin (UEA-I) conjugated to fluorescein.  UEA-I has been used previously to
detect Fucα(1-2)Gal glycoproteins in cells and tissues.24, 25
Hippocampal neurons were cultured for 23 DIV before treatment with PAO and
fluorescein-conjugated UEA-I.  Following fixation and immunostaining with anti-tau
antibody, neurons were visualized by fluorescence microscopy.  As shown in Figure 2.8,
24
A B C
UEA I Anti-tau Overlay
Figure 2.8.  Costaining of neurons with UEA-I lectin and an anti-tau antibody. Neurons were stained
with (A) fluorescein-conjugated UEA-I lectin and (B) an anti-tau antibody in the presence of 10 µm
PAO.  C) Overlay of both images (yellow indicates colocalization).  UEA-I lectin labels neurons on the
cell body and along axons and dendrites.  Scale bars, 45 µm
A B C
UEA I Anti-tau Overlay
Figure 2.9. Lipid extraction using MeOH/CHCl3 did not diminish UEA-I lectin labeling.  Costaining of
neurons with (A) UEA-I lectin (green) and (B) anti-tau antibody (red) in the presence of 10 µM PAO
after lipid extraction.  C) Overlay of both images (yellow indicates colocalization).  Scale bars, 45 µm
UEA-I lectin specifically labels neurons on the cell body and along axons and dendrites.17
Furthermore, UEA-I displays a punctate staining consistent with localization to synapses.
To validate that the UEA-I lectin was labeling glycoproteins rather than simply
interacting with the lipid membrane, neurons were delipidated prior to treatment with
UEA-I lectin.  Specifically, neurons cultured for 23 DIV were treated with a
MeOH/CHCl3 mixture followed by incubation with PAO and fluorescein-conjugated
UEA-I.  In Figure 2.9, we see that lipid extraction prior to treatment with UEA-I lectin
does not diminish the labeling of neurons, and we see staining of the cell body and
neurite processes.17
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Fucα(1-2)Gal carbohydrates modulate neuronal outgrowth
Once we established the presence of Fucα(1-2)Gal lectins and glycoproteins in
neurons, we sought to investigate the impact of Fucα(1-2)Gal carbohydrates on neuronal
function.  First, we examined whether the association of Fucα(1-2)Gal with potential
lectins would elicit a neuronal response.  As carbohydrates have weak binding affinities
for lectins (Kassoc =103 – 106 M)26, we used polyacrylamide polymers bearing multiple
Fucα(1-2)Gal epitopes (FucGal-PAA) to stimulate endogenous lectins and enhance the
interactions.  Treatment of hippocampal neurons with the multivalent polymers was
carried out by Dr. Kalovidouris and revealed a striking impact on neuronal morphology.17
Hippocampal neurons were cultured for 20 hours before treatment with the
polyacrylamide polymers in solution for an additional 24 hours.  Neurons were then
immunostained with anti-tau antibodies and quantified for neurite outgrowth.
Remarkably, the multivalent polymers stimulated neurite outgrowth by 50 ± 6% relative
to the untreated control (Figure 2.10).  Furthermore, the growth-inducing activity was
specific to the Fucα(1-2)Gal disaccharide, as polymers lacking the disaccharide (PAA)
had no significant effect.  Polymers containing N-acetylglucosamine (GlcNAc-PAA) or
D-galactose (Gal-PAA) failed to promote neuronal outgrowth.  Interestingly, other L-Fuc-
bearing polymers, such as L-Fuc PAA (Fuc-PAA) and Fucα(1-3)GlcNAc (FucGlcNAc-
PAA), displayed neuronal processes similar to those of untreated cells, suggesting that
the observed neuritogenic activity is specific for Fucα(1-2)Gal.
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Figure 2.10. Fucα(1-2)Gal promotes neuronal growth. Neurite outgrowth was quantified by
measuring the longest neurite per cell after treatment with 130 µM of the indicated compounds.  Error
bars represent SEM from 100 total neurons in two separate experiments.
We next examined whether Fucα(1-2)Gal glycoproteins are associated with
neuronal growth pathways.  Since previous studies have shown that lectins activate and
promote the clustering of glycoproteins at the cell surface,27 we used exogenous lectins to
stimulate the Fucα(1-2)Gal glycoproteins found in neurons.  Dr. Kalovidouris treated
hippocampal neurons cultured for 20 hours with the Fucα(1-2)Gal specific lectins UEA-I
or Lotus tetragonolobus lectin (LTL)24 and found that neurite outgrowth was stimulated
by 21 ± 6% and 20 ± 6%, respectively, relative to the untreated control (Figure 2.11)17.
Competition experiments with 400-fold excess probe 1 abolished the stimulatory activity
of UEA-I and LTL.  Additionally, lectins selective for other carbohydrates such as
glucosamine (wheat germ agglutinin, WGA) or Fucα(1-3)Gal (Anguilla anguilla
agglutinin, AAA)24 did not enhance neurite outgrowth.  Together, these results suggest
that the growth-promoting activity is specific for Fucα(1-2)Gal carbohydrates.
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Figure 2.11. Only the Fucα(1-2)Gal-selective lectins UEA I and LTL stimulate neuronal growth.
Neurite outgrowth was quantified after treatment with 3.7 µM of the indicated lectins.  Error bars
represent SEM from 100 total neurons in two separate experiments.
These intriguing observartions suggest that Fucα(1-2)Gal saccharides may play
important roles in neuronal growth.  To further investigate the effect of Fucα(1-2)Gal
saccharides on neuronal morphology and development, we treated neuronal cultures with
the unnatural sugar analog 2-dGal.  As described earlier, disruption of Fucα(1-2)Gal
linkages using 2-dGal caused amnesia in animals and prevented the maintenance of LTP.9
-- 11, 28  We first examined the effect of 2-dGal on the expression of the Fucα(1-2)Gal
epitope.  Hippocampal neurons were grown for 1 day and then treated with or without 30
mM 2-dGal.  After 4 days, cells were harvested and cell lysates were probed by Western
blotting using the anti-Fucα(1-2)Gal antibody A46-B/B10.  Consistent with earlier
studies,8, 29 treatment of neurons with 2-dGal disrupted synthesis of the Fucα(1-2)Gal
epitope on glycoproteins (Figure 2.12).17  Specifically, a significant decrease of the
Fucα(1-2)Gal signal on the two major glycoproteins detected in untreated neurons was
observed.
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Figure 2.12. Treatment with 2-dGal diminishes the expression of the Fucα(1-2)Gal epitope on
glycoproteins. Neurons were treated for 4 days with or without 30 mM 2-dGal. Protein lysates were
then analyzed by Western blotting using antibody A46-B/B10. Lane 1: Untreated neurons. Lane 2:
Neurons treated with 30 mM 2-dGal. Each lane contains 75 µg total protein.
Once we confirmed that treatment with 2-dGal was indeed disrupting the
synthesis of Fucα(1-2)Gal linkages on neuronal glycoproteins, we examined the effects
of 2-dGal on neuronal morphology.  A dose-response experiment was initially performed
to determine the minimum concentration of 2-dGal needed to elicit an effect.  Neurons
were treated with varying concentrations of 2-dGal for 2 days before immunostaining
with anti-tau antibodies.  As shown in Figure 2.13, treatment with increasing
concentrations of 2-dGal caused neurite retraction.17  Importantly, no cellular toxicity was
observed at concentrations up to 30 mM 2-dGal, as demonstrated by trypan blue staining,
adherence of the cells to the coverslip, and healthy cellular morphology.  A concentration
of 15 mM was used in subsequent experiments, as it was the minimal concentration that
produced a strong effect on neurite outgrowth.
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Figure 2.13. Hippocampal neurons treated with varying concentrations of 2-dGal exhibit increasing
defects in neuronal growth.  After 1 day in culture, neurons were treated with the specified
concentrations of 2-dGal for 2 days, followed by immunostaining with anti-tau antibodies.
To fully establish the effects of 2-dGal on neuronal morphology, hippocampal
neurons were incubated with 2-dGal and compared to those incubated with 3-deoxy-D-
galactose (3-dGal), D-galactose (D-Gal), and untreated neurons.  Neurons were treated
under four different conditions: (1) incubation with 15 mM 2-dGal for 2 days, (2)
incubation with 15 mM 3-dGal for 2 days, (3) incubation with 15 mM 2-dGal for 2 days
followed by incubation with 75 mM D-Gal for 2 days, or (4) no treatment for 2 days.
Following treatment with the various molecules, cells were fixed and immunostained
with anti-tau antibodies.  As shown in Figure 2.14, 2-dGal causes severe morphological
defects in cultured neurons.17  Compared to untreated cells that have many neuronal
processes, cells treated with 2-dGal exhibited severely stunted neurites and failed to form
synapses.  Interestingly, the effects were fully reversible: subsequent addition of D-Gal
led to regeneration of neuronal processes.  In contrast, addition of 3-dGal had no impact
Untreated 1 mM 2-dGal 5 mM 2-dGal
10 mM 2-dGal 15 mM 2-dGal 30 mM 2-dGal
30
Untreated 2-dGal
2-dGal + D-Gal 3-dGal
Figure 2.14. Treatment of hippocampal neurons with 2-dGal (15 mM), but not 3-dGal (15 mM), for 2
days inhibits neuronal growth. The effects of 2-dGal can be reversed by subsequent treatment with D-
Gal (75 mM) for an additional 2 days. Neurons were immunostained with anti-tau antibodies.
on neurite outgrowth.  These results are consistent with a stimulatory role for Fucα(1-
2)Gal glycoproteins and demonstrate the striking influence of Fucα (1-2)Gal
carbohydrates in neuronal growth.
Discussion
Our studies demonstrate that Fucα(1-2)Gal carbohydrates are capable of
modulating neuronal outgrowth and morphology.  We provide strong evidence for the
presence of Fucα(1-2)Gal lectin receptors and glycoproteins in hippocampal neurons.
Specifically, we have determined that proteins binding the Fucα(1-2)Gal disaccharide
and proteins expressing this epitope are found on the cell surface, along axons and
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dendrites, and at synapses.  Furthermore, we show that preventing formation of Fucα(1-
2)Gal linkages by treatment with 2-dGal induces dramatic morphological changes and
severely stunts neurite outgrowth.  Consistent with a role for Fucα(1-2)Gal carbohydrates
in neuronal growth, stimulation of either Fucα(1-2)Gal lectins or glycoproteins with
exogenous Fucα(1-2)Gal polymers or lectins promotes neurite outgrowth.  Together,
these findings identify a novel, carbohydrate-mediated pathway for modulating neuronal
growth and development.
Manipulation of Fucα(1-2)Gal–associated proteins using small molecule and
lectin probes elicited striking effects on neuronal morphology, suggesting that Fucα(1-
2)Gal may be important for maintaining structural plasticity.  This prospect may shed
light on behavioral and electrophysiological studies implicating Fucα(1-2)Gal in long-
term memory formation.  Alterations in neuronal morphology, such as dynamic changes
in dendritic spine number and shape, occur during memory consolidation and LTP.30, 31
Additionally, protein glycosylation has been shown to be necessary for maintaining
LTP.32  Furthermore, fucose incorporation levels increase following learning tasks and
have been shown to enhance memory retention and LTP.5, 14 -- 16  One possibility is that
Fucα(1-2)Gal and its associated proteins are involved in structural remodeling events that
contribute to synaptic plasticity and are thereby impacting learning and memory
processes in the brain.
With the establishment of Fucα(1-2)Gal glycoproteins and lectins in neurons,
identification of these proteins is necessary to enable a detailed study of Fucα(1-2)Gal
saccharides and their impact on neuronal communication.  Using affinity-based and
genomics tools, we will first identify and study Fucα(1-2)Gal glycoproteins in the
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hippocampus.  With the demonstration of the use of small molecules in culture and the
development of a chemical tool in probe 1, we will also detect and seek to identify the
first Fucα(1-2)Gal lectins in neurons.
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Experimental Procedures for Chapter 2
Buffers and Reagents:
Chemicals and molecular biology reagents were purchased from Fisher (Fairlawn, NJ)
unless stated otherwise.  Protease inhibitors were purchased from Aldrich Chemicals (St.
Louis, MO) and Alexis Biochemicals (San Diego, CA).  Cell culture media was
purchased from Gibco BRL (Grand Island, NY).  German glass coverslips were
purchased from Carolina Biologicals (Burlington, NC).
Embryonic Hippocampal Dissection:   
Timed-pregnant Sprague-Dawley rats were purchased from Charles River Laboratories
(Kingston, Mass) and housed at the Caltech laboratory animal facilities.  Timed-pregnant
rats at embryonic day 18 (E18) were euthanized by carbon dioxide inhalation.  A quick
C-section was performed and the uterus placed in a 100 x 15 mm petri dish containing
ice-cold Calcium and Magnesium Free Hank’s Balanced Salt Solution (CMF-HBSS) and
transferred to the tissue culture dissecting hood.  The embryos were decapitated and the
heads placed onto the lid of a petri dish on ice.  The skin and skull were cut to expose the
brain and the brain was removed by “scooping” it out from the olfactory bulbs to the
cerebellum and placed in a new dish on ice containing CMF-HBSS.  Under a dissecting
microscope, the cerebral hemispheres were separated from the midbrain and the
cerebellum and meninges were removed.  The hippocampus was cut out with a scalpel
and placed in a separate dish with CMF-HBSS and kept on ice until all hippocampi were
removed.
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Hippocampal Neuronal Cultures:
Hippocampal neuronal cultures were prepared using a modified version of the Goslin,
Asmussen, and Banker18 protocol.  Embryos at the E18 stage were obtained from timed-
pregnant Sprague-Dawley rats.  The hippocampus from each embryo was dissected as
described above.  All the hippocampi from one prep were transferred to a 15 mL conical
containing 4.5 mL of ice-cold CMF-HBSS.  Trypsin (2.5%, no EDTA) was added to 5
mL and the tissue was digested for 15 min at 37 °C.  The trypsin solution was removed
and the tissue rinsed with 5 mL of CMF-HBSS three times.  Cells were then dissociated
from the tissue in 1 mL of CMF-HBSS by passing through a P1000 pipet tip 15 to 20
times.  The cells were counted with a hemacytometer, diluted into Minimal Eagle’s
Medium (MEM) plus 10% fetal bovine serum, and seeded on poly-DL-ornithine (15
µg/mL; Sigma)-coated 15 mm glass coverslips at a density of 75 cells/mm2 (100
µL/coverslip) for 30 min.  After this time, 500 µL of supplemented neurobasal medium
(neurobasal media without L-glutamine, 2 mM L-glutamine, 250 µg/mL penicillin / 250
µg/mL streptomycin, 1X antibiotic-antimycotic, 1X B-27 supplement, 50 mM kynurenic
acid in 1 N NaOH) was added to each coverslip. The cultures were maintained in 5% CO2
at 37 °C until specified.
Immunocytochemistry of Hippocampal Neuronal Cultures:
After specified days in culture, hippocampal neurons on coverslips were used for
immunostaining.  Cells were rinsed one time with PBS (120 mM NaCl, 2.7 mM KCl, 10
mM phosphate buffer pH 7.4), fixed in 4% paraformaldehyde for 20 min at rt, washed
twice with PBS, permeabilized in 0.3% Triton X-100 for 5 min at rt, and washed twice
35
with PBS.  Non-specific binding was blocked by incubating with 3% BSA for 1 h at rt
and then rinsing once with PBS.  Cells were then incubated with anti-tau antibodies
(rabbit polyclonal, 1:600; Sigma) in 3% BSA for 2 h at rt.  Excess antibody was rinsed
away 5 times with PBS.  The secondary antibody, anti-rabbit IgG AlexaFluor 488 (1:600;
Molecular Probes), was added for 1 h at 37 °C in 3% BSA.  Excess secondary antibody
was washed off 5 times with PBS.  The coverslips were mounted onto glass slides using
Vectashield mounting medium (Vector Labs) and sealed with clear nail polish.  Cells
were then subjected to confocal laser microscopy.
Staining of Hippocampal Neurons with Probe 1 and Fluorescein-Conjugated UEA-I
Lectin:
Hippocampal neuronal cultures were prepared as described above and maintained at 37
°C, 5% CO2 in supplemented neurobasal medium.  After specified days in culture, the
medium was replaced, and neurons were treated with the endocytosis inhibitor
phenylarsine oxide19 (PAO; 4 µL in DMSO, final concentration 10 µM) and either probe
1 (24 µL in PBS, final concentration 3 mM), biotin (24 µL in PBS, final concentration 3
mM), or fluorescein-conjugated UEA I lectin (4 µL, 1:100 final dilution) in
supplemented neurobasal medium (400 µL final volume) for 1 h at 37 °C, 5% CO2.  After
1 h, neurons were rinsed twice with PBS, fixed in 4% paraformaldehyde for 20 min at rt,
washed twice with PBS, permeabilized in 0.3% Triton X-100 for 5 min at rt, and washed
another 2 times with PBS.  Non-specific binding was blocked with 3% BSA for 1 h at rt
and then rinsed once with PBS.  Anti-tau antibody (rabbit polyclonal, 1:400; Sigma),
anti-MAP2 antibody (mouse monoclonal, 1:400; Sigma), or anti-synapsin I antibody
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(rabbit polyclonal, 1:250; Sigma) was added in 3% BSA for 2 h at rt and the excess
antibody rinsed off 5 times with PBS.  Probe 1 was detected with streptavidin conjugated
to AlexaFluor 488 (1:200; Molecular Probes) while anti-tau, anti-MAP2, or anti-synapsin
I antibodies were detected with secondary antibodies conjugated to AlexaFluor 568
(1:600; Molecular Probes).  Both dye-conjugated streptavidin and secondary antibodies
were added in 3% BSA for 1 h at 37 °C and the excess reagent washed off 5 times with
PBS.  Coverslips were then mounted onto slides with Vectashield, sealed, and imaged
using confocal laser microscopy.
De-lipidation of Neurons with MeOH/CHCl3 Prior to Treatment with Probe 1 and
Fluorescein-Conjugated UEA I Lectin:
To confirm that probe 1 was binding specifically to proteins rather than interacting with
the membrane lipids, neurons were delipidated following the protocol of Yavin and
Yavin.20  Briefly, after specified days in culture, cells were rinsed once with PBS then
exposed to MeOH/CHCl3 (1/2 by vol) for 15 min at –80 °C.  After removing the
MeOH/CHCl3 mixture, coverslips were dried at rt and neurons were then stained as
described above.
Treatment of Neuronal Cultures with 2-Deoxy-D-Galactose, 3-Deoxy-D-Galactose, and
D-Galactose:
Hippocampal neurons were plated on poly-DL-ornithine-coated glass coverslips as
described above.  After one day in culture, the medium was replaced with fresh medium,
and the small molecules added.  A dose-response experiment was initially performed to
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determine the minimum concentration of 2-dGal needed to elicit an effect.  Neurons were
treated with varying concentrations of 2-dGal (1, 5, 10, 15, or 30 mM in 25 µL PBS with
475 µL of supplemented neurobasal medium) for 2 days before immunostaining with
anti-tau antibodies as described above.  A concentration of 15 mM was used in
subsequent experiments, as it produced a strong effect on neurite outgrowth.  Cells were
treated as above under 4 different conditions: (1) incubation with 15 mM 2-dGal for 2
days, (2) incubation with 15 mM 3-deoxy-D-galactose for 2 days, (3) incubation with 15
mM 2-dGal for 2 days followed by incubation with 75 mM D-galactose for 2 days, or (4)
no treatment for 2 days.  After adding the small molecules, cultures were incubated at 37
°C, 5% CO2, then washed once with PBS, and immunostained with the anti-tau antibody
as described above.
Analysis of the Fucα(1-2)Gal Epitope on Neuronal Proteins Following Treatment with 2-
Deoxy-D-Galactose:
In addition to cells plated on coverslips, hippocampal neurons were grown in 30 mm
dishes and treated with or without 30 mM 2-dGal (25 µL in PBS with 475 µL
supplemented neurobasal medium).  After 4 days, cells were harvested with 2.5% trypsin,
lysed with 1 % boiling SDS with protease inhibitors, and cell lysates probed by Western
blotting using the anti-Fucα(1-2)Gal antibody A46-B/B1013.  Protein concentrations of
the neuronal lysates were determined using the BCA Protein Assay (Pierce).  Equal
amounts of total protein were resolved by 10% SDS-PAGE, and proteins were transferred
to PVDF membrane (Millipore) in 20 mM Tris-Cl pH 8.6/ 120 mM glycine/ 20%
methanol.  Western blots were blocked for 1 h with 3% periodated BSA33 and rinsed with
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TBST (50 mM Tris-Cl pH 7.4/ 150 mM NaCl/ 0.1% Tween-20).  Blots were incubated
with anti-Fucα(1-2)Gal antibody A46-B/B10 (0.5 µg/mL) in TBST overnight at 4 °C
with constant rocking, then rinsed and washed twice for 10 min with TBST.
Immunoreactivity was visualized by incubation with a horseradish peroxidase conjugated
goat anti-mouse antibody (1:2500; Pierce) in TBST for 1 h followed by a rinse and four
washes of 20 min with TBST.  Blots were visualized by chemiluminescence using ECL
reagents (Amersham) on X-Omat R film (Kodak).
Confocal Laser Microscopy:
All cells were imaged on a Zeiss Axiovert 100M inverted confocal laser microscope in
the Biological Imaging Center in the Beckman Institute.  The images were captured with
LSM Pascal software using a 40X plan-neofluar air objective or a 63X plan-neofluar oil
objective.  All cells were excited with 488 nm and 568 nm light.  The scan speed,
collection mode, and zoom were changed slightly, as were the gain and black levels, for
optimization of the images.  All images were then copied into and analyzed by Adobe
Photoshop.
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Chapter 3: Fucose α(1-2) Galactose-Containing Glycoproteins are Prevalent in the
Brain and Regulate Neuronal Morphology∗†
Background
Fucose α(1-2) galactose (Fucα(1-2)Gal) carbohydrates have been implicated in
modulating neuronal communication that underlies learning and memory.  For instance,
preventing formation of Fucα(1-2)Gal linkages by incorporation of 2-deoxy-D-galactose
(2-dGal) into glycan chains has been reported to cause reversible amnesia in animals.1, 2
The sugar analog 2-dGal precludes the formation of Fucα(1-2)Gal linkages because it
lacks the hydroxyl group at the C-2 position and inhibits the formation of a specific 1-2
glycosidic linkage with fucose.1  2-dGal has also been shown to interfere with the
maintenance of long-term potentiation (LTP), a leading model for memory formation in
the brain.3, 4  Additionally, injection of a monoclonal antibody selective for Fucα(1-2)Gal
also impairs memory formation in animals,5, 6 presumably by blocking the Fucα(1-2)Gal
epitope.  These intriguing results suggest important roles for Fucα(1-2)Gal-associated
proteins in regulating neuronal communication.
Interestingly, evidence suggests that protein fucosylation is regulated in response
to neuronal activity.  Both task-specific learning and LTP have been shown to induce the
fucosylation of proteins at the synapse, with linear incorporation of [14C]-labeled fucose
                                                 
∗ Identification of synapsin I was carried out by Wen I. Luo, a former graduate student in the Hsieh-Wilson
laboratory, and Heather E. Murrey, a graduate student in the Hsieh-Wilson laboratory.  Analysis of the
Fucα(1-2)Gal epitope on synapsin function was performed by Heather E. Murrey
† Portions of this chapter were taken from H.E. Murrey et al. (2006) Proc. Natl. Acad. Sci. USA 103, 21 –
26.
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up to 3 hours after training and a 26% increase in tritium-labeled fucose levels 24 hours
after the learning task.7, 8  Addition of exogenous L-fucose or 2’-fucosyllactose (but not
D-fucose, D-lactose, or 3-fucosyllactose) was also found to enhance LTP in hippocampal
slices.9  Furthermore, the activity of fucosyltransferases, enzymes involved in the transfer
of fucose to glycoproteins, has also been demonstrated to increase substantially during
synaptogenesis and passive avoidance training.10, 11  Together, these studies suggest that
protein fucosylation is likely a highly regulated process that contributes to synaptic
plasticity.
Although there is significant evidence implicating Fucα(1-2)Gal carbohydrates in
learning and memory processes, little is known about the location of this epitope or the
molecular mechanisms by which it impacts neuronal communication.  Notably, no
Fucα(1-2)Gal glycoproteins have been characterized from the brain.  As our initial data
demonstrated the presence of Fucα(1-2)Gal glycoproteins in neurons (Chapter 2), we
sought to further characterize the Fucα (1-2)Gal glycoproteins present in the
hippocampus.  We have established that Fucα(1-2)Gal carbohydrates are expressed on
several glycoproteins during neuronal development and demonstrate that synapsin Ia and
Ib are the predominant Fucα(1-2)Gal glycoproteins in the adult rat brain.
Fucα(1-2)Gal glycoproteins are enriched at synapses
We previously demonstrated the presence of potential glycoproteins specific for
the Fucα(1-2)Gal disaccharide using the Ulex europeaus agglutinin I (UEA-I) lectin.12
To allow for further characterization and identification of Fucα(1-2)Gal glycoproteins,
we obtained an antibody selective for Fucα(1-2)Gal epitopes (Figure 3.1),6 the mouse
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Figure 3.1. Trisaccharide Fucα(1-2)Galβ(1-4)GlcNAc recognized by antibody A46-B/B10
monoclonal antibody A46-B/B10, which was a generous gift from Dr. Uwe Karsten.
Importantly, antibody A46-B/B10 has been shown to induce amnesia in animals5,
suggesting that it recognizes one or more physiologically relevant epitopes.
Fucose-containing glycoproteins are known to exist in the brain, but they have not
been conclusively established to be present at synapses.  Therefore, we sought to
establish the location of Fucα(1-2)Gal glycoproteins in neurons.  Hippocampal neurons
were cultured for 14 DIV to allow for synapse formation and were subsequently fixed,
permeabilized, and coimmunostained with antibody A46-B/B10 and an antibody against
the neuronal marker tubulin.  The neurons were visualized by confocal laser microscopy
following incubation with appropriate dye-conjugated secondary antibodies. Using
antibody A46-B/B10, we found that Fucα(1-2)Gal glycoproteins are located on the
surface of neurons and are highly enriched at synapses.13  In Figure 3.2, we see that
Fucα(1-2)Gal glycoproteins (green) have remarkable punctate staining along axons and
dendrites (red) as well as some staining on the cell body surface.  As controls in every
experiment, the primary and secondary antibodies were tested individually and in various
combinations to ensure that the observed fluorescence was due to the desired antibody.
In addition, several rounds of optimization of blocking conditions, wash conditions,
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Figure 3.2. Costaining of neurons with Fucα(1-2)Gal antibody A46-B/B10 and an anti-tubulin
antibody.  A) A46-B/B10 antibody staining (green).  B) Anti-tubulin labeling shows axons, dendrites,
and cell bodies.  C) Overlay of A46-B/B10 antibody and anti-tubulin labeling (yellow indicates
colocalization) shows that Fucα(1-2)Gal staining is distributed on the cell body and along dendrites and
axons. Scale bar, 25 µm
Figure 3.3. Lipid extraction of cellular membranes does not abolish staining with antibody A46-B/B10.
Neurons were delipidated with MeOH/CHCl3 before staining with (A) antibody A46-B/B10 (green) and
(B) an anti-tau antibody (red). C) Overlay of images (yellow indicates colocalization). Scale bar, 25 µm
antibody concentrations, incubation times and temperatures were necessary to optimize
signal and minimize the non-specific background.
To confirm that the Fucα(1-2)Gal antibody was labeling glycoproteins rather than
simply interacting with the lipid membrane, neurons were delipidated14 prior to treatment
with antibody A46-B/B10.  Specifically, neurons cultured for 20 days were treated with a
methanol/chloroform (MeOH/CHCl3) mixture followed by coimmunostaining with
antibody A46-B/B10 and an anti-tau antibody.  Indeed, lipid extraction prior to
immunostaining does not diminish the labeling of neurons, and we see staining of the cell
body and neurite processes (Figure 3.3),13 confirming the labeling of glycoproteins rather
than glycolipids.
A B C
Fucα(1-2)Gal Anti-tubulin Overlay
A B C
Fucα(1-2)Gal Anti-tau Overlay
46
Figure 3.4. Costaining of neurons cultured for 14 DIV with Fucα(1-2)Gal antibody A46-B/B10 and
either an anti-synapsin antibody or an anti-spinophilin antibody. A) A46-B/B10 antibody staining
(green) colocalizes with anti-synapsin staining (red), suggesting that Fucα(1-2)Gal glycoproteins are
enriched at presynaptic terminals. B) A46-B/B10 antibody staining (green) does not colocalize with
anti-spinophilin staining (red), suggesting that Fucα(1-2)Gal glycoproteins  are mostly apposed to post-
synaptic terminals. Arrows indicate colocalization in (A) and apposition in (B). Scale bars, 10 µm
The punctate staining pattern observed suggested that Fucα(1-2)Gal glycoproteins
were present at synapses.  To validate this result, we compared the subcellular
localization of the Fucα(1-2)Gal glycoproteins to that of synapsin I and spinophilin.
Synapsin I is a conventional marker for presynaptic terminals while spinophilin is found
at postsynaptic terminals.15, 16  We performed co-localization studies of antibody A46-
B/B10 with synapsin I antibodies (Figure 3.4A).13  The results confirmed the presence of
Fucα(1-2)Gal at pre-synapses, as antibody A46-B/B10 labeling (green) overlapped with
58 ± 2% of synapses labeled with anti-synapsin I (red).  Colocalization studies of
antibody A46-B/B10 with spinophilin antibodies (Figure 3.4B) revealed mostly
apposition of Fucα(1-2)Gal labeling (green) with spinophilin labeling (red).13  These
findings demonstrate that Fucα(1-2)Gal sugars are enriched on glycoproteins present at
presynaptic terminals.
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Figure 3.5. Fucα (1-2)Gal is expressed on several glycoproteins in the hippocampus and is
developmentally regulated. Comparison of the Fucα(1-2)Gal glycoproteins present in E18 rat
hippocampus, embryonic hippocampal neurons cultured for the indicated times, and adult rat
hippocampus.  Cellular lysates were resolved by SDS-PAGE and probed by Western blotting with
antibody A46-B/B10.
Expression of Fucα(1-2)Gal on glycoproteins is developmentally regulated
In order to better understand the precise function(s) of the Fucα(1-2)Gal motif on
glycoproteins, it is essential to identify specific glycoproteins displaying the disaccharide
at the synapse.  Toward this end, we evaluated the expression of the Fucα(1-2)Gal
epitope on glycoproteins in the hippocampus.  Cellular lysates from adult rat
hippocampus, E18 hippocampus, and cultured embryonic hippocampal neurons were
analyzed by Western blotting with antibody A46-B/B10.  We found that the Fucα(1-
2)Gal epitope is expressed on distinct proteins during neuronal development (Figure
3.5).13
In E18 hippocampal tissue, three major glycoproteins of approximately 35, 60,
and 65 kDa are prominently observed.  Expression of Fucα(1-2)Gal on these
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glycoproteins is drastically reduced in the adult hippocampus.  Significantly, the major
Fucα(1-2)Gal glycoproteins of 73 and 75 kDa found in mature cultured neurons and adult
brain tissue are distinct from those in embryonic tissue.  Interestingly, expression of
Fucα(1-2)Gal is observed on multiple glycoproteins in developing neurons cultured for 4
and 7 DIV, periods when axons, dendrites, and functional synapses are being formed.
These results indicate that Fucα(1-2)Gal saccharides are synthesized on distinct proteins
and the expression levels of Fucα(1-2)Gal and/or the associated glycoproteins vary
dramatically with age and development.
Synapsin Ia and Ib are the major Fucα(1-2)Gal glycoproteins in the hippocampus
We next sought to identify the major Fucα(1-2)Gal glycoproteins found in the
brain.   Attempts to purify Fucα(1-2)Gal glycoproteins from extracts using antibody A46-
B/B10 were unsuccessful due to the relatively weak binding affinity of the antibody for
the carbohydrate epitope.  Therefore, potential glycoproteins were identified using a
combination of subcellular fractionation, gel electrophoresis, and matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS).13  Heather E.
Murrey took adult rat hippocampal lysates enriched in synaptic proteins and resolved the
proteins using 1D or 2D gel electrophoresis.  Proteins were then analyzed by Western
blotting with antibody A46-B/B10 or stained with Coomassie brilliant blue.  As observed
previously, two major glycoproteins of approximately 73 and 75 kDa were recognized by
antibody A46-B/B10.  The proteins of interest were identified by immunoblotting and
excised from the corresponding Coomassie-stained gel, digested with trypsin, and
identified by MALDI-TOF MS.  The predominant proteins in adult rat brain were
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Figure 3.6. Synapsins Ia and Ib are Fucα(1-2)Gal glycoproteins. Immunoprecipitated synapsin I is
detected by antibody A46-B/B10. Input, lysate used for immunoprecipitation; Control,
immunoprecipitation in the absence of antibody; Synapsin IP, immunoprecipitated synapsin. Upper
panel was immunoblotted with an anti-synapsin antibody, and Lower panel was probed with antibody
A46-B/B10. Synapsin Ia appeared in darker exposures of the blot.
identified as synapsin Ia and Ib, synaptic-vesicle-associated proteins involved in
neurotransmitter release.
To confirm the fucosylation of synapsin Ia and Ib, the proteins were
immunoprecipitated and examined by Western blotting with antibody A46-B/B10.13
Indeed, Heather E. Murrey found that the immunoprecipitated proteins were specifically
recognized by the antibody (Figure 3.6).  Furthermore, she established that only
synapsins Ia and Ib, but not the synapsin II or III isoforms, are covalently modified by the
critical Fucα(1-2)Gal epitope and that fucosylation protects synapsin from degradation
by the calcium-activated protease calpain.
Fucosylation regulates synapsin expression in neurons and neurite outgrowth
As our results indicate a critical role for fucosylation on synapsin function, we
wanted to further investigate this phenomenon in neurons.  Toward this end, the effect of
2-dGal on synapsin fucosylation in neurons was examined.  After culturing neurons for 7
DIV to allow for adequate synapsin expression, Heather E. Murrey treated the cultures
with either 2-dGal or 6-deoxy-D-Galactose (6-dGal).  Expression of synapsin was
dramatically reduced by treatment with 2-dGal, but not 6-dGal (Figure 3.7).13  Moreover,
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Figure 3.7. Expression of synapsin I was reduced by treatment with 2-dGal but not 6-dGal. Cortical
neurons were treated with 2- or 6-dGal (15 mM) for 3 days. Protein lysates were analyzed by Western
blotting for the indicated proteins.  A significant reduction in the expression of synapsin I was observed,
whereas other synaptic proteins were unaffected by the 2-dGal treatment.
the effects of 2-dGal were specific to synapsin, as the expression of other synaptic
proteins was unchanged by the 2-dGal treatment.
 Because the synapsins play important roles in neuronal development and
synaptogenesis, we investigated how 2-dGal might influence neuronal growth and
morphology.  Previously, we saw that treatment with 2-dGal severely stunted neurite
outgrowth of young, 2 DIV neurons (Chapter 2).  With the identification of synapsins
Ia/Ib as the major Fucα(1-2)Gal glycoproteins in mature cultures and adult hippocampus,
we treated older cultures with 2-dGal and also found dramatic effects on neuronal
morphology.  Hippocampal neurons were cultured for 7 DIV as above to establish
synapses and subsequently incubated for 3-5 days with 2-dGal at various concentrations
(Figure 3.8).  Treatment with 2-dGal induced retraction of neurites and collapse of
synapses, whereas 6-dGal had no effect.13  Interestingly, the inhibitory effects of 2-dGal
could be rescued by subsequent treatment with D-galactose (D-Gal).  In fact, treatment
with D -Gal caused a 2.06 ±  0.14-fold rescue of neurite length, presumably by
reestablishing the Fucα(1-2)Gal linkage.  Collectively, we have found that treatment of
cultured neurons at different developmental stages with 2-dGal impairs neurite outgrowth
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Figure 3.8. The morphology of hippocampal neurons is modulated by 2-dGal in a concentration-
dependent manner. A) C57BL/6 mice neurons were cultured for 7 DIV and treated with 2-dGal for 5
days at the concentrations indicated. Neurite retraction becomes more pronounced with increasing
concentration of 2-dGal. B) Rat neurons were cultured for 7 DIV and treated with either 2- or 6-dGal
(15 mM) for 3 days. The effects of 2-dGal were partially reversed by treatment with D-Gal.
and disrupts neuronal connections, suggesting that Fucα(1-2)Gal is important for
maintaining neuronal plasticity.
One potential mechanism by which 2-dGal might influence neuronal morphology
is by regulating the function and/or expression of synapsin in presynaptic terminals.  To
examine the relative contribution of synapsin I to the effects elicited by 2-dGal, neurons
from synapsin I-deficient or wild-type mice were cultured for 2 days, treated with or
without 2-dGal for 3 days, and then examined by fluorescence microscopy (Figure 3.9).13
We found that neurons from wild-type mice treated with 2-dGal had shorter neurites than
their wild-type counterparts (compare Fig 3.9C and A).  Interestingly, the effects of
defucosylation with 2-dGal were more pronounced than the elimination of the synapsin I
gene (compare Figure 3.9C and B). Furthermore, treatment with 2-dGal induced more
neurite retraction in wild-type relative to synapsin-deficient neurons (compare Figure
3.9C and D).  Although the length and extensive overlap of neuronal processes for
Untreated 2-dGal + D-Gal6-dGal2-dGal
2-dGal (5 mM) 2-dGal (10 mM) 2-dGal (15 mM)Untreated
A
B
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Figure 3.9. Synapsin-deficient neurons display reduced neurite retraction relative to wild-type neurons
upon treatment with 2-dGal. Neurons from synapsin I-deficient (Syn KO) or wild-type (WT) mice were
cultured for 2 days, treated in the presence (C, D) or absence (A, B) of 2-dGal (15 mM) for 3 days, and
examined by confocal fluorescence microscopy. (E) Neurons treated with 2-dGal were analyzed for
neurite length and the mean neurite length was compared by the ANOVA test.  Error bars represent the
SEM from 50 total neurons in three separate experiments (*, P < 0.03). Scale bar, 75 µm
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untreated wild-type neurons precluded a quantitative analysis of neurite length, 2-dGal
treatment led to neurite retraction and enabled quantification.  We found that synapsin-
deficient neurons displayed 1.17-fold longer neurites than wild-type neurons upon
treatment with 2-dGal (Figure 3.9E).
Discussion
Increasing evidence has linked synaptic activity with changes in the levels of
protein fucosylation in the brain.  Both task-specific learning and LTP have been shown
to enhance protein fucosylation.7, 8  Additionally, the activity of fucosyltransferases
substantially increases during synaptogenesis and upon passive avoidance training in
animals.10, 11  These studies suggest that protein fucosylation may be dynamically
regulated at the synapse.  Our findings that synapsins Ia and Ib are the major Fucα(1-
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2)Gal glycoproteins in maturing neuronal cultures and the adult rat hippocampus are the
first studies identifying synaptic proteins modified by the Fucα(1-2)Gal epitope.
The synapsins are a family of highly conserved neuron-specific proteins that are
associated with synaptic vesicles.17  The synapsins have been shown to modulate
neurotransmitter release by regulating the supply of releasable vesicles during periods of
high activity.17, 18  In addition, synapsin I has recently been found to control synaptic
vesicle dynamics in developing neurons via a cAMP-dependent pathway.19  Accordingly,
synapsin-deficient mice exhibit reduced numbers of synaptic vesicles within nerve
terminals and display significant alterations in neuronal transmitter release and synaptic
depression.17, 20  Our findings indicate that fucosylation of synapsin critically impacts its
expression and turnover in presynaptic terminals.  Moreover, fucosylation of synapsin
increases its half-life and protects against degradation by the calcium-activated protease
calpain.
Furthermore, our results demonstrate that synapsin fucosylation has a significant
impact on neuronal growth and morphology.  We used the small molecule 2-dGal, an
inhibitor of Fucα(1-2)Gal linkages, as a tool for defucosylating synapsin and for
investigating the role of the carbohydrate on synapsin function.  Treatment of neurons
with 2-dGal led to stunted neurite outgrowth and delayed synapse formation.  Moreover,
significant differences were observed between wild-type and synapsin-deficient neurons
upon treatment with 2-dGal.  The extent of neurite retraction in synapsin-deficient mice is
less pronounced, most likely because the primary target of 2-dGal, synapsin I, is missing.
Indeed, the bar graph in Figure 3.10 likely represents a lower estimate of the contribution
of synapsin, because neurites from synapsin-deficient neurons are shorter than those from
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wild-type neurons before treatment with 2-dGal.  From these results, we propose that
defucosylation may disrupt synapsin function, leading to its degradation and neurite
retraction.  Although further studies are needed to resolve whether synapsin fucosylation
stimulates or inhibits neurite outgrowth, our results strongly support the notion that
synapsin fucosylation plays a role in modulating neuronal growth and morphology.
Our findings also implicate other Fucα(1-2)Gal glycoproteins in regulating
neuronal morphology.  We have shown that Fucα(1-2)Gal carbohydrates are not limited
to synapsin but are found on additional proteins in developing neurons (Figure 3.6).
Expression of the sugar and/or these glycoproteins changes dramatically during neuronal
development.  We found that defucosylation of synapsin did not fully account for the
striking neurite retraction induced by 2-dGal, suggesting that 2-dGal may disrupt the
fucosylation of other Fucα(1-2)Gal glycoproteins that influence neuronal morphology.
Moreover, 2-dGal was still capable of inducing neurite retraction in synapsin-deficient
neurons and in young cultured neurons where synapsin expression is low.12  Thus,
Fucα(1-2)Gal sugars appear to  regulate the functions of multiple proteins involved in
neuronal morphology and exert their effects via distinct molecular mechanisms.
Collectively, our studies provide new molecular-level insights into the role of
Fucα(1-2)Gal in mediating the communication between neurons.  The finding that
synapsin Ia and Ib are fucose-containing glycoproteins is significant because it suggests
that fucosyl saccharides may be involved in regulating neurotransmitter release and/or
synaptogenesis.  The modification of synapsin with Fucα(1-2)Gal fits accordingly with
our model of fucosyl saccharides serving as a targeting element for proteins.  Although
further experiments are needed to show that the Fucα(1-2)Gal epitope directs the
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targeting of synapsin to the synapse, it is clear that fucosylation directly affects synapsin
stability and, thus, its functions at the synapse.
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Experimental Procedures for Chapter 3
Buffers and Reagents:
Chemicals and molecular biology reagents were purchased from Fisher (Fairlawn, NJ)
unless stated otherwise.  Protease inhibitors were purchased from Aldrich Chemicals (St.
Louis, MO) and Alexis Biochemicals (San Diego, CA).  Cell culture media was
purchased from Gibco BRL (Grand Island, NY).  German glass coverslips were
purchased from Carolina Biologicals (Burlington, NC).
Embryonic Hippocampal Dissection:   
Embryonic tissue was dissected as described in Chapter 2.
Neuronal Cultures and Immunocytochemistry:
Hippocampal neurons were cultured and immunostained as described in Chapter 2.
Synapsin I knockout mice21 were generously provided by H. T. Kao and P. Greengard
(The Rockefeller University, New York).  Antibody A46-B/B106 was a generous gift
from U. Karsten (Max-Delbrick Centre for Molecular Medicine, Berlin-Buch, Germany)
and was incubated in 3% BSA (2.5 µg/mL) overnight at 4 °C.  The anti-tubulin (1:500;
Sigma), anti-synapsin (1:5,000; Molecular Probes), and anti-spinophilin [1:10,000 (14)]
antibodies were added in 3% BSA for 2 h at 37 °C.  Goat anti-mouse IgM AlexaFluor
488 or goat anti-rabbit IgG AlexaFluor 568 (1:250; Molecular Probes) were added for 1 h
at 37 °C in 3% BSA.
57
De-lipidation of Neurons with MeOH/CHCl3 Prior to Immunostaining with Antibody
A46-B/B10:
Delipidation of neurons with MeOH/CHCl3 was performed as described in Chapter 2.
Antibody A46-B/B10 (2.5 µg/mL) was added in 3% BSA overnight at 4 °C.  Anti-tau
antibodies (1:500; Sigma) were added in 3% BSA for 2 h at 37 °C.  Goat anti-mouse IgM
AlexaFluor 488 or goat anti-rabbit IgG AlexaFluor 568 (1:250; Molecular Probes) were
added for 1 h at 37 °C in 3% BSA.
Adult Hippocampal Dissection and Lysis:
100 g male Sprague-Dawley rats were purchased from Charles River Laboratories
(Kingston, Mass) and housed at the Caltech laboratory animal facilities.  Rats were
anesthetized with carbon dioxide for 2 min and immediately euthanized by decapitation
with a guillotine (Kent Scientific Co.).  The brain was promptly removed and placed on
ice.  The hippocampus was quickly dissected and homogenized in 50 mM Tris-HCl pH
8.0/ 150 mM NaCl/ 0.2% sodium deoxycholate/ 1% Nonidet P-40 supplemented with
protease inhibitors with a glass Dounce homogenizer and sonicated briefly.  Supernatants
were clarified by centrifugation at 12,000 x g for 10 min, and protein concentrations were
determined by using the BCA protein assay (Pierce).
Western Blotting:
Protein concentration of hippocampal lysates was determined using the BCA protein
assay (Pierce).  Lysates were resolved on 10% acrylamide-SDS gels.  Proteins were
transferred to polyvinylidene difluoride (PVDF) membrane (Millipore) for at least 12 h in
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20 mM Tris-Cl pH 8.6/ 120 mM glycine/ 20% methanol.  Western blots were blocked for
1 h with HIO4-BSA and rinsed with TBST (50 mM Tris-Cl pH 7.4/ 150 mM NaCl/ 0.1%
Tween-20).  Blots were incubated with 0.5 mg/mL antibody A46-B/B10 in TBST
overnight at 4 °C with constant rocking, then rinsed and washed twice for 10 min with
TBST.  Immunoreactivity was visualized by incubation with a horse-radish peroxidase
conjugated goat anti-mouse antibody (1:2500; Pierce) in TBST for 1 h followed by a
rinse and four washes of 20 min in TBST.  Blots were visualized by chemiluminescence
using Pico Chemiluminescent Substrate (Pierce).
Treatment of Cells with Deoxy-Galactose Analogues:
Rat neuronal cultures were treated after 7 days in culture as described in Chapter 2.
Neurons from C57BL/6 and synapsin I knockout postnatal day 0 mice were cultured for 2
days and then treated for 3 days with 15 mM 2-dGal.
Morphometric Analysis:
For quantitative analysis of neurite length, 50 cells were analyzed per experimental
condition for three separate experiments.  Only cells with neurites longer than one cell
body diameter were measured.  The length of the longest neurite was measured using
NIH Image 1.62 software, and mean neurite lengths were compared by the ANOVA test
using the statistical analysis program Statview 4.0.
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Chapter 4:  Discovery of Fucα(1-2)Gal-Specific Lectins in the Developing Brain∗
Background
L-Fucose is a monosaccharide enriched at synapses that exists primarily as a
terminal modification to glycan chains.  A majority of the fucose-containing
carbohydrates are complex N-linked sugars containing two or more peripheral branches
or, less often, hybrid structures.1, 2  Fucose is frequently linked to the C-3 and C-6
positions of N-acetylglucosamine or to the C-2 position of galactose.3  We are
particularly interested in the fucoseα(1-2)galactose (Fucα(1-2)Gal) disaccharide, as
several studies have implicated this disaccharide in learning and memory processes.
Preventing the formation of Fucα(1-2)Gal linkages on glycan chains using 2-deoxy-D-
galactose (2-dGal) causes reversible amnesia in animals.4 -- 6  As 2-dGal specifically
inhibits the incorporation of fucose into glycoproteins,4, 7, 8 it is likely that Fucα(1-2)Gal
glycoproteins contribute to memory storage.  Moreover, protein fucosylation has been
shown to increase in response to neuronal activity, with fucose incorporation and
fucosyltransferase activity increasing in direct response to learning and long-term
potentiation (LTP).9 -- 11  These remarkable results suggest critical roles for Fucα(1-2)Gal
glycoproteins in regulating the neuronal communication underlying learning and
memory.
With such considerable evidence supporting a significant role for Fucα(1-2)Gal
glycoproteins in cell-cell communication, it is likely that Fucα(1-2)Gal lectins are also
                                                 
∗ Synthesis of capture probe 2 and control molecule 3 was carried out by Dr. Lori W. Lee, a former
graduate student in the Hsieh-Wilson laboratory, and Dr. Stacey A. Kalovidouris, a former postdoctoral
scholar in the Hsieh-Wilson laboratory. Synthesis of polymer 5 is being carried out by Arif Wibowo, a
graduate student in the Hsieh-Wilson laboratory.
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involved in regulating neuronal communication.  Indeed, several studies have
demonstrated the importance of Fucα(1-2)Gal lectins in information processing and
memory formation.  Injection of a monoclonal antibody specific for the Fucα(1-2)Gal
epitope drastically reduced retention of a learned task and had an amnesic effect in both
chicks and rats.12, 13  Presumably, the amnesic effect is a result of the antibody preventing
the interaction between fucosylated glycoproteins and lectins.  Additionally, treatment
with exogenous fucosyl saccharides in both in vivo and in vitro models was found to
enhance LTP.14, 15  Together, these studies provide considerable evidence supporting a
role for Fucα(1-2)Gal lectins in modulating neuronal communication.
The binding of lectins to carbohydrate motifs is an important phenomenon crucial
to many cellular functions, including pathogen recognition, cellular adhesion, and
lymphocyte trafficking.16 -- 18  Although no Fucα(1-2)Gal-specific lectins have been
characterized from animals, the total number of animal lectins identified is ever
increasing.  Most animal lectins identified can be classified into five major groups: C-
type or Ca2+-dependent lectins, galactose-binding galectins, P-type phospohorylated
mannose receptors, I-type immunoglobulin-like sugar-binding proteins, and L-type
lectins related to leguminous plant lectins.19  Despite the enormous diversity among
lectins, the sugar-binding activity can be attributed to the carbohydrate-recognition
domain (CRD), typically a globular region of less than 200 amino acids.18  The CRD
among the individual groups of lectins are related to each other in amino acid sequence,
thus enabling classification into the separate groups.
While there are increasing numbers of animal lectins being identified each year,
there have been no Fucα(1-2)Gal-specific lectins reported to date.  As such, we had to
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first determine whether Fucα(1-2)Gal lectins exist in the brain.  Indeed, we have
demonstrated that Fucα(1-2)Gal lectins are present in the mammalian brain and are found
on the cell body and neurites of hippocampal neurons (Chapter 2).  Furthermore, we
found that stimulation of the lectins with Fucα(1-2)Gal dramatically promotes neurite
outgrowth.  Our studies are the first report of Fucα(1-2)Gal lectins in the brain and
identify a novel carbohydrate-mediated pathway for neuronal growth.  Through the use of
various chemical probes, we now seek to identify Fucα(1-2)Gal lectins from the brain in
order to gain a molecular-level understanding of the impact of fucosyl saccharides on
neuronal function.
Design of Fucα(1-2)Gal capture probe 2
Recent studies in our laboratory have established that Fucα(1-2)Gal lectins exist
in the mammalian brain and are involved in a novel pathway that promotes neuronal
growth.  To facilitate isolation and identification of these lectins from the brain, our
laboratory has synthesized chemical probe 2 (Figure 4.1).  Chemical probe 2 was
synthesized by Dr. Lori W. Lee and Dr. Stacey A. Kalovidouris and contains the Fucα(1-
2)Gal moiety as the critical molecular recognition element as well as the biotin moiety for
detection, as was found in probe 1 (Chapter 2).  Importantly, probe 2 also contains a
trifluoromethylphenyldiazirine (diazirine) moiety, which enables the capture of target
lectins via photoactivated crosslinking.  By forming a covalent linkage to the proteins of
interest, the protein-probe complex can withstand rigorous washing in the purification
process.  Additionally, control molecule 3 was synthesized to test the specificity of probe
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2, as it lacks the Fucα(1-2)Gal disaccharide while still carrying the diazirine and biotin
moieties.
Photoaffinity labeling is a well-established technique to elucidate ligand-
biomolecule interactions.  This technique has been used to successfully label enzymes,
protein structures, and RNA/DNA structures.20 -- 23 Typically, the substrate is modified to
bear the photoreactive element and radiolabels are incorporated to allow for the
identification of the binding site.  The covalently labeled protein can also be visualized
with a variety of other techniques, such as spectroscopic analysis and fluorophore
methods.22
Combining the power of photoaffinity labeling with the advantages of
biotinylating substrates creates a chemical probe that allows for a covalent bond to be
formed between the protein of interest and the probe and provides a sturdy handle to
isolate the complex with the use of immobilized avidin.  The biotin moiety also provides
the advantage of sensitive, non-radioactive detection of labeled protein using
Figure 4.1. Monovalent capture probe 2 and control molecule 3.  The three main features of probe 2 are
the Fucα(1-2)Gal disaccharide (red) for protein binding, the photoreactive diazirine moiety (blue) for
crosslinking to bound proteins, and the biotin handle (green) for affinity column purification.  Control
molecule 3 acts as a specificity marker because it lacks the Fucα(1-2)Gal disaccharide while still
bearing the diazirine moiety (blue) and biotin handle (green).
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streptavidin-conjugated-horseradish peroxidase (HRP).  The photoreactive, covalent
crosslinking element is thought to overcome the weak binding affinities often observed of
lectins for their carbohydrate ligands.24  A variety of biotinylated photoreactive probes
have been synthesized and successfully used to study and isolate protein-substrate
complexes, ranging from γ-secretase inhibitors to glucose transporter ligands.25, 26
Fucα(1-2)Gal capture probe 2 labels known fucose-binding lectins AAA and UEA-I
With probe 2 in hand, we first validated the design of the capture probe and tried
to label known fucose-binding lectins.  Purified samples of the known fucose-binding
lectins AAA from Anguilla anguilla and UEA-I from Ulex europaeus27, 28 were incubated
with or without probe 2 and control molecule 3, irradiated with UV light, and analyzed
by Western blotting using streptavidin-HRP.  Notably, AAA and UEA-I lectins were
detected by streptavidin-HRP only after treatment with probe 2 and UV irradiation
(Figure 4.2A).  No signal was observed when either lectin was incubated with control
molecule 3 or when UV irradiation was omitted.  The lectins were also analyzed by
Coomassie stain (Figure 4.2B) to confirm that equivalent amounts of protein were present
in each sample.  From these results, we were confident that probe 2 was capable of
specifically labeling fucose-binding lectins and proceeded to label Fucα(1-2)Gal lectins
in embryonic neurons.
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Capture of Fucα(1-2)Gal lectins from dissociated neurons
Once we established the labeling of known fucose-binding lectins, we proceeded
to use probe 2 for the capture of Fucα(1-2)Gal lectins.  Dissociated neurons prepared
from E18 rats were incubated with probe 2 in neurobasal medium.  We initially chose to
label dissociated neurons because cellular staining with probe 1 (Chapter 1) gave
significant signal and thus we reasoned that Fucα(1-2)Gal lectins would be amenable to
labeling with probe 2 on the cell surface, as the probe probably does not cross the cell
membranes.  Following incubation, the cells were irradiated on ice with UV light (365
nm).  The optimal time for crosslinking proteins to the probe without damaging the cells
was determined to be 2 h.  Cells were then lysed with boiling 1% SDS to solubilize all
proteins.  The proteins were resolved by SDS-PAGE and probed by Western blotting
using streptavidin-HRP. As shown in Figure 4.3, probe 2 indeed captured proteins from
embryonic neurons.  At least two major proteins at approximately 55 and 40 kDa, and
several minor proteins, were captured by probe 2 (Figure 4.3, lane 1 vs. 2 and 3).
Figure 4.2. Capture probe 2 specifically labels the fucose-binding lectins AAA and UEA-I.  A) Purified
samples of AAA and UEA-I were treated with probe 2 and control molecule 3 and analyzed for specific
labeling by streptavidin-HRP. B) Samples were also analyzed by Coomassie stain for total protein content.
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Investigations into the specificity of the target lectins
To confirm that probe 2 is binding selectively through the Fucα (1-2)Gal
disaccharide, we performed competition experiments with several sugars. Several
alternative sugars were synthesized by Dr. Kalovidouris that vary in the configuration of
the fucose saccharide in the model Fucα(1-2)Gal disaccharide (Figure 4.4A).
Dissociated forebrain cells were first incubated with Fucα(1-2)Gal-OEt disaccharide, L-
FucαOEt, or D-FucαOEt (each at 150 mM) for 2 h and then with probe 2 (0.3 mM) for
an additional 2 h.  Cells were irradiated and lysed as described above and the proteins
were resolved and detected as above by Western blotting (Figure 4.4B).  The proteins
captured by probe 2 (lane 1) are no longer detected upon treatment with the Fucα(1-
2)Gal-OEt competitor (lane 2).  Treatment with L-FucαOEt or D-FucαOEt reduced the
concentrations of proteins captured, however the reduction was incomplete (lanes 3 and
4).  These studies demonstrate that the lectins are recognizing the probe specifically via
the sugar moiety.  Moreover, comparison of the L-FucαOEt or D-FucαOEt
Figure 4.3. Capture probe 2 labels distinct proteins in dissociated neurons.  Lane 1: Proteins from
dissociated cells captured by probe 2. Lane 2: Proteins captured by control molecule 3. Lane 3: Proteins
non-specifically detected by streptavidin-HRP in untreated cells
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monosaccharides with the disaccharide competitor suggests that recognition of the
galactose moiety by the target lectins is an important factor.
Purification of Fucα(1-2)Gal lectins from dissociated neurons
To identify the target proteins, probe 2 was used to isolate Fucα(1-2)Gal lectins
from embryonic brain.  Dissociated cells were incubated with probe 2, irradiated, and
lysed as described above.  After lysis, the proteins were first pre-cleared with agarose
beads and then captured with streptavidin-agarose beads.  Eluted proteins were resolved
by SDS-PAGE and probed by Western blotting using streptavidin-HRP.  As shown in
Figure 4.5, the major Fucα(1-2)Gal lectins were the same as those observed in the
capture experiment in Figure 4.3.  Furthermore, control molecule 3 failed to capture any
Fucα(1-2)Gal lectins.
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Figure 4.4.  Probe 2 specifically labels Fucα(1-2)Gal lectins in dissociated neurons.  A) Compounds
synthesized for competition experiments with probe 2.  B) Competition binding with specified
molecules shows that probe 2 is specifically labeling Fucα(1-2)Gal lectins.  Lane  1: Cells treated with
probe 2 alone (0.3 mM).  Lane 2: Cells treated first with Fucα(1-2)GalOEt (150 mM) followed by
probe 2 (0.3 mM).  Lane 3: Cells treated with L-FucαOEt (150 mM) followed by probe 2 (0.3 mM).
Lane 4: Cells treated with D-FucαOEt (150 mM) followed by treatment with probe 2 (0.3 mM)
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With such promising capture of Fucα(1-2)Gal-specific lectins by probe 2, we
thought identification of these proteins would follow accordingly.  Dissociated neurons
were labeled with probe 2 and captured proteins were isolated on streptavidin beads as
described above.  Eluted proteins were resolved by SDS-PAGE and visualized by
Coomassie staining to allow for subsequent identification by mass spectrometry (MS).
As shown in Figure 4.6, very little protein was detected by Coomassie staining.  More
importantly, there were no differences observed between samples labeled with probe 2 or
control molecule 3.  Furthermore, none of the proteins observed by Coomassie staining
corresponded to proteins detected by streptavidin-HRP, which visualizes lectins
crosslinked to probe 2.  Subsequently, we performed these experiments on a larger scale
to try to enhance the total amount of proteins isolated.  However, efforts to isolate the
lectins in sufficient quantity to be visualized by Coomassie staining and for subsequent
MS analysis were unsuccessful.
Figure 4.5.  Fucα(1-2)Gal lectins were specifically captured by probe 2 and isolated on a streptavidin
column.  Dissociated cells were incubated with probe 2 (lane 1) or control molecule 3  (lane 2),
crosslinked with UV light, and then lysed for protein purification. Eluents from the streptavidin
columns were resolved and analyzed by Western blotting with streptavidin-HRP.
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In an effort to enrich the target lectins before MS analysis, we performed
subcellular fractionation experiments with labeled neurons before isolating over
streptavidin beads.  Dissociated neurons were labeled with probe 2 as described above
and lysed in 0.32 M sucrose by homogenization.  Cell lysates were separated into soluble
S2 and membrane P2 fractions.  The S2 fractions were further separated by anion
exchange chromatography on a Q-sepharose column.  The fractions with the highest
absorbance at 280 nm were resolved by SDS-PAGE and analyzed by Western blotting
with streptavidin-HRP. As shown in Figure 4.7A, several proteins labeled with probe 2
were divided into different fractions and were separated from proteins labeled with
control molecule 3.  The separation of labeled proteins by anion exchange was promising
for the enrichment of target lectins.  However, when the fractions were analyzed by
Coomassie staining, very little to no protein was detected (Figure 4.7B).
Figure 4.6.  Coomassie stain analysis of total protein captured on streptavidin column after probe 2
labeling.  Lane 1: Protein labeled with probe 2;  Lane 2: Protein labeled with control molecule 3
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Our studies indicate quantitative capture of the lectins using streptavidin beads.
However, the crosslinking step seems to be inefficient and we estimate that less than 1%
of the total protein in the cells is being crosslinked to the probe.  These results suggest
that the probe has weak binding affinity for the lectins and/or the lectins are present in
very low cellular abundance.  These challenging obstacles have made it quite difficult to
capture sufficient quantities of the Fucα(1-2)Gal lectins for MS analysis from embryonic
tissue.  As a result, we proceeded to isolate target lectins from protein lysates generated
from rat pup brain, as older animals will presumably contain larger quantities of protein.
Identification of Fucα(1-2)Gal lectins from rat brain lysate
In trying to identify Fucα(1-2)Gal lectins from embryonic tissue, we encountered
several complications.  Mainly, we were unable to isolate sufficient quantities of target
Figure 4.7. Subcellular fractionation of protein lysates labeled with probe 2 and control molecule 3.  A)
Streptavidin-HRP Western blot of subcellular fractions further separated by anion exchange
chromatography.  Lanes 1 – 3: S2 fractions labeled with probe 2.  Lanes 4 – 5: S2 fractions labeled with
control molecule 3.  Lane 6: P2 fraction labeled with probe 2.  Lane 7: P2 fraction labeled with control
molecule 3.  B) Coomassie stain analysis of the same subcellular fractions as in A)
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lectins for MS analysis.  Therefore, we decided to move towards using rat pup protein
lysate for identifying Fucα(1-2)Gal lectins (Figure 4.8).
Whole cortices from rat pups were lysed by sonication before incubating over
agarose beads to eliminate any endogenous, agarose-binding proteins.  Lysates were then
labeled with probe 2 or control molecule 3 and then captured over streptavidin-agarose
beads.  Target lectins were eluted off the streptavidin column, resolved by SDS-PAGE,
and analyzed by Western blotting and silver staining.  As shown in Figure 4.9A, several
proteins were enriched with probe 2 labeling as compared to control molecule 3 labeling.
Importantly, the silver stain analysis of these samples also showed enrichment of proteins
labeled with probe 2, indicating capture of potential Fucα(1-2)Gal lectins (Figure 4.9B).
Although weak binding was observed, protein bands from both lanes of the silver
stain were excised, digested with trypsin, and compared by MS analysis.  From this
Figure 4.8.  Scheme depicting the strategy by which probe 2 is used to label and identify Fucα(1-2)Gal
lectins from neuronal protein lysate
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analysis, we identified the first potential Fucα(1-2)Gal lectins: Na+/K+ ATPase and
importin β.  Despite low signal from the MS data, we were able to duplicate the
identification of these two proteins from two separate labeling experiments.  These
putative protein hits were quite exciting, as both of these proteins have crucial roles in
cellular function.  The Na+/K+ ATPase is essential in generating the electrochemical
gradient necessary to maintain cellular potential.29  Importin β  is a major transport
receptor crucial to the import of proteins into the nucleus.30
To confirm that these proteins are Fucα(1-2)Gal lectins, lysates labeled with
probe 2 were resolved by SDS-PAGE and then analyzed by Western blotting using either
Na+/K+ ATPase or importin β antibodies.  Unfortunately, we did not detect any signal at
the predicted molecular weights of either protein (Figure 4.10).  Moreover, further
attempts at confirming these results with more labeling experiments using probe 2 were
not possible.  Limited quantities of probe 2 were generated in the laboratory and after
Figure 4.9.  Distinct proteins from rat pup lysate were captured and isolated by probe 2.  A) Western
blot analysis of rat pup lysate labeled with probe 2 (lane 1) and control molecule 3 (lane 2).  B) Silver
stain analysis of proteins labeled with either probe 2 (lane 1) or control molecule 3 (lane 2)
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many rounds of optimization and experimental trials, we had exhausted all stocks
synthesized.
Capture of Fucα(1-2)Gal lectins using multivalent polymers
Although we have used probe 2 to label several potential Fucα(1-2)Gal lectins in
embryonic brain, efforts to capture and isolate sufficient quantities of target lectins for
MS analysis were only mildly successful.  Therefore, we proceeded to use multivalent
probes to enhance our ability to capture larger quantities of lectins.  As carbohydrates
have weak binding affinities for lectins (Kassoc = 103 – 106 M), multivalent probes greatly
enhance the binding affinity and cluster of lectins to their targets.24, 31  Remarkably, we
found that polyacrylamide polymers displaying multiple Fucα(1-2)Gal epitopes
stimulated neurite outgrowth by 50 ± 6% (Chapter 2).  To establish whether the polymers
would function to isolate target lectins, we first determined if these polyacrylamide
Figure 4.10.  Protein lysate labeled with probe 2 did not confirm identification of potential Fucα(1-
2)Gal lectins.  Lane 1: Labeled lysate probed with Na+/K+ ATPase antibody (predicted molecular
weight is 112 kDa); Lane 2: Labeled lysate probed with importin β antibody (predicted molecular
weight is 97 kDa)
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polymers displaying multiple Fucα(1-2)Gal epitopes (polymer 4, Glycotech Corporation,
Figure 4.11) could label target lectins.
Dissociated neurons from embryonic rat brains were lysed, and proteins were
fractionated into S2 and P2 fractions, resolved by SDS-PAGE, and transferred to
polyvinylidene fluoride (PVDF) membranes.  The lectins were visualized by Far-Western
analysis where the blot was probed with polymer 4, followed by incubation with
streptavidin-HRP.  Importantly, we found that polymer 4 labeled similar lectins to those
labeled with monovalent probe 2 (Figure 4.12).  Comparing lane 2 versus lane 3, we see
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Figure 4.11.  Multivalent polymer 4 displays multiple Fucα(1-2)Gal epitopes (red) and multiple biotin
moieties (green).  Specifically, polymer 4 has a polyacrylamide backbone and is 20% loaded with
Fucα(1-2)Gal (approximately 40 units) and 5% loaded with biotin (approximately 20 units).
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many of the same protein bands detected with multivalent polymer 4 as were labeled with
monovalent probe 2, respectively.
As the polyacrylamide polymers successfully labeled target lectins, we proceeded
to capture the lectins using polymer 4.  In combination with streptavidin beads, polymer 4
was used to generate a Fucα(1-2)Gal affinity column for the isolation of desired lectins
(Figure 4.13).
Figure 4.12. Labeling of proteins from dissociated embryonic neurons using the multivalent or
monovalent probe.  Proteins from the S2 (lane 1) or P2 (lane 2) fractions were labeled on blot with
multivalent polymer 4. Lane 3: Intact cells were labeled with the monovalent probe 2 and lysed.
Figure 4.13.  Strategy for identification of Fucα(1-2)Gal lectins from neuronal protein lysate using
multivalent polymer 4
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First, we used the known fucose-binding lectin UEA-I to optimize binding and
capture conditions.   The Fucα(1-2)Gal affinity column was generated by incubating
polymer 4 with streptavidin beads.  After unbound polymer was removed, UEA-I lectin
was bound on the column and then eluted with binding buffer containing 200 mM L-
fucose.  This procedure enabled specific capture of the UEA-I lectin by the Fucα(1-2)Gal
affinity column compared to the control streptavidin column (Figure 4.14).
With successful isolation of the UEA-I lectin by the Fucα(1-2)Gal affinity
column, we proceeded to capture the fucose-specific lectins from rat pup protein lysate.
Rat pup cortical tissue was lysed by sonication with ice-cold binding buffer before
incubating with the Fucα(1-2)Gal affinity column.  As a positive control, we added UEA-
I lectin to the lysate mixture before incubating with the affinity column.  Again, we were
able to specifically capture the UEA-I lectin (Figure 4.15).  However, the efficiency of
lectin capture from the lysate was not very high and resulted in smeared protein bands
visualized in the silver staining.
Figure 4.14. Capture of purified UEA-I lectin using the multivalent Fucα(1-2)Gal polymer 4.  Equal
amounts of UEA-I lectin (10 µg) were bound on the Fucα(1-2)Gal affinity column and streptavidin
control column. Lane 1: Eluent from Fucα(1-2)Gal affinity column; Lane 2: Eluent from streptavidin
column
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To enhance the efficiency of the Fucα(1-2)Gal affinity column, we optimized the
lysis and binding conditions to facilitate the capture of Fucα(1-2)Gal lectins.  Rat pup
cortical tissue was lysed in ice-cold binding buffer that contained no detergent, and non-
specific proteins were reduced by pre-clearing the lysate over a streptavidin column for 1
h at room temperature prior to incubation with the Fucα(1-2)Gal affinity column for 4 h
at room temperature.  Again, we added UEA-I to the lysate prior to incubating with either
affinity column as a positive control.  Furthermore, we added a competition affinity
column where L-fucose (1000-fold excess) was added to the lysate during incubation
with the Fucα(1-2)Gal affinity column.  The competition column would better indicate
which captured proteins are fucose-specific lectins and will allow us to eliminate false
positives that might arise from non-specific crosslinking to proteins or non-specific
Figure 4.15. Capture of UEA-I and Fucα(1-2)Gal lectins from rat pup lysate.  UEA-I lectin was
specifically captured by the affinity column (Lane 1).  Other Fucα(1-2)Gal lectins were also captured,
albeit to a lesser extent, exhibited by the smear of protein bands in Lane 1.  Lane 1: Eluent from
Fucα(1-2)Gal affinity column; Lane 2: Eluent from streptavidin column
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binding of proteins to the polyacrylamide backbone or streptavidin beads.  As shown in
Figure 4.16, several proteins were enriched on the Fucα(1-2)Gal affinity column relative
to the control column where lectin binding was competitively inhibited by L-fucose
(arrows).  Moreover, the Fucα(1-2)Gal affinity column captured the positive control
lectin UEA-I (arrowhead).  The bands from the affinity and control columns were
excised, digested with trypsin, and compared by MS analysis.  Although specific proteins
were visualized by silver staining, the total amount of protein isolated from each band
was too low and MS signal strength was weak and inconclusive.
Design of new multivalent Fucα(1-2)Gal probes for isolating neuronal lectins
As described in Chapter 2 and above, our studies demonstrate that Fucα(1-2)Gal
lectins exist in the mammalian brain and are involved in a novel pathway for neuronal
growth.  Using polyacrylamide polymers displaying multiple disaccharide and biotin
Figure 4.16. Capture of Fucα(1-2)Gal  lectins from rat pup lysate using the Fucα(-2)Gal affinity
column. Proteins at ~ 65, 80, 140, and 300 kDa (arrows) were selectively captured by the Fucα(1-2)Gal
affinity column (Lane 1).  UEA-I lectin was also specifically captured (arrowhead, Lane 1). Lane 1:
Eluent from Fucα(1-2)Gal affinity column; Lane 2: Eluent from L-fucose competition column
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moieties, we created an affinity column to capture the target lectins.  While this approach
has enhanced the binding of desired lectins to the Fucα(1-2)Gal affinity column, we were
still unable to isolate sufficient quantities of proteins for MS analysis.  Therefore, we feel
that we can significantly improve our ability to capture the lectins by generating a
multivalent, biotinylated glycopolymer containing photoreactive crosslinking groups.
Arif Wibowo will synthesize polymer 5, which has Fucα(1-2)Gal recognition elements,
photoreactive phenyl azide groups, and is end-labeled with biotin (Figure 14.17).
The presence of multiple Fucα(1-2)Gal sugars on a polyacrylamide backbone
ensures the binding of polymer 5 to the target lectins and the biotin group provides a
convenient handle for capturing the lectins by affinity chromatography.  The
photoreactive phenyl azide moieties should allow more efficient lectin capture by
forming a covalent linkage to the target proteins.  Importantly, the addition of a covalent
linkage between the polymer and protein of interest allows for vigorous washing to
reduce non-specifically bound proteins.  Phenyl azides were chosen as a starting point
Figure 4.17.  Design of multivalent capture polymer 5 .  Polymer 5 will have a polyacrylamide
backbone, multiple Fucα(1-2)Gal epitopes (red), photoreactive phenyl azide groups (blue), and will be
end-labled with biotin (green).
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because they are well precedented and can be readily synthesized from commercially
available starting materials.  Other photoactivatable groups such as
trifluorometylphenyldiazirines (as in probe 2) and benzophenone are also possible.
Discussion
Our overall goal is to understand the molecular mechanisms by which fucose-
containing carbohydrates regulate neuronal communication and function.  As fucose-
associated lectins and glycoproteins from the brain have not been identified previously,
we developed new methods to identify and characterize these proteins.  Our studies have
revealed that such proteins do indeed exist in the mammalian brain and play a key role in
the regulation of synaptic proteins and neuronal morphology.
We have established that Fucα(1-2)Gal-associated proteins participate in a novel
carbohydrate-mediated pathway for regulating neuronal growth (Chapter 2).32
Specifically, we developed a chemical probe for detecting Fucα(1-2)Gal lectins in
neurons and found that the probe bound to the cell body and neurites of hippocampal
neurons.  Furthermore, we discovered that association of the fucose disaccharide with
these lectins dramatically promotes neurite outgrowth.  Additionally, we have found that
Fucα(1-2)Gal glycoproteins are prevalent in the developing brain and that synapsin Ia
and Ib are the major Fucα(1-2)Gal glycoproteins in the adult rat brain (Chapter 3).33
Notably, fucosylation protects the synapsins from rapid degradation, while inhibition of
fucosylation drastically impairs the outgrowth of neurons and delays synapse formation.
Together, our studies suggest that Fucα(1-2)Gal carbohydrates play a significant role in
regulating neuronal growth and communication.
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Once we established the existence of Fucα(1-2)Gal lectins in neurons, we sought
to identify and characterize these proteins.  As no Fucα(1-2)Gal lectins have been
previously reported and no methods existed to isolate such proteins, we designed a
chemical probe (probe 2) and developed a strategy for the capture and identification of
the target lectins from the brain.  The probe includes 3 key features: 1) a Fucα(1-2)Gal
recognition element for binding to lectins, 2) a photoactivatable group to covalently
crosslink the probe to target lectins, and 3) a biotin handle for affinity capture.  Efforts to
isolate lectins from embryonic tissue in sufficient quantity for MS analysis were
unsuccessful. Attempts to enrich the captured lectins using subcellular fractionation were
also unsuccessful.  Based on our experimental results, we estimated that less than 1% of
the total protein in the cells is being crosslinked to the probe.  This suggests that the
probe has a weak binding affinity for the target lectins and/or that the target lectins are of
very low abundance in the embryonic cell.
Unable to characterize Fucα(1-2)Gal lectins from embryonic neurons, we
proceeded to isolate target lectins from juvenile rats in an attempt to obtain sufficient
quantities of protein for MS analysis.  This strategy was a move in the right direction and
provided the identity of the first potential Fucα(1-2)Gal lectins, the Na+/K+ ATPase and
importin β.  Despite such promising results, we were unable to confirm the identity of
these putative lectins by Western blotting and further attempts to isolate more proteins
using probe 2 were not possible.  As such, our efforts then focused on using multivalent
probes to capture the target lectins.
Carbohydrates typically have weak binding affinities for lectins,24 making it quite
difficult to study and identify specific lectin targets.  Multivalent probes can help
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overcome these challenges by enhancing the binding affinity between the carbohydrate
and lectin of interest.31  We used a biotinylated polyacrylamide polymer containing
multiple Fucα(1-2)Gal epitopes and generated a lectin affinity column using streptavidin
beads.  Although weak binding was observed, we found that we could successfully
capture Fucα(1-2)Gal-specific lectins from neuronal lysates.  Importantly, the affinity
column captured the protein UEA-I, a Fucα(1-2)Gal-specific plant lectin27, 28 which was
added to the lysates as a positive control.  After many rounds of optimization of
experimental conditions, several proteins were enriched relative to a control column in
which lectin binding was competitively inhibited with L-fucose (Figure 4.16).  Despite
such distinct protein staining, the efficiency of capture was not enhanced relative to that
of the first probe (probe 2), which was monovalent but contained a photoactivatable
crosslinking group.  Based on these results, we have reasoned that adding photo-
crosslinking groups to multivalent polymers should solve these technical issues,
combining enhanced lectin binding with efficient covalent capture.  Efforts in the lab
have now focused on generating multivalent polymers that will enable control over
carbohydrate density, type, and number of photo-crosslinking groups, and allow for the
addition of biotin or other moieties for affinity chromatography.
Although we were unable to conclusively identify any Fucα(1-2)Gal lectins from
neurons, the possibility that the Na+/K+ ATPase and importin β are fucose-specific lectins
leads to significant implications.  First, the Na+/K+ ATPase is an essential protein crucial
to cellular function.  It creates an electrochemical gradient across the cell membrane by
exchanging cytoplasmic Na+ for extracellular K+ in a 3:2 ratio.29  This gradient plays a
role in maintaining cell volume and pH, in keeping the cell resting membrane potential,
84
and in providing the energy necessary for the secondary transport of other ions, solutes
and water across the cell membrane.  The Na+/K+ ATPase is made up of two main
subunits, α and β, both of which exist in different isoforms.  Interestingly, the β subunit
is known to be glycosylated, and the glycoproteins have been shown to contain fucose
carbohydrates.29, 34, 35  Although glycosylation is not essential to formation, cell
trafficking, or activity of the Na+/K+ ATPase, glycosylation aids in the structural stability
of β subunits and also specifies the assembly of distinct α and β subunits.29  As such, one
possibility is that the α  subunit may serve as a lectin receptor, binding to the
carbohydrate expressed on the β subunit.  Upon binding, correct αβ  heterodimer
assembly can occur and thus allow delivery of an active Na+/K+ ATPase to the cell
membrane.  In this instance, fucosylation of the Na+/K+ ATPase would be acting as an
intracellular signal modulating the assembly of different αβ heterodimers, generating
separate Na+/K+ ATPase isozymes with distinct functions.
The possibility that importin β  is also a fucose-specific lectin has significant
implications for nuclear transport and neuronal communication.  Importin β is a key
protein essential to nuclear transport in most mammalian cells and can bind
macromolecular cargo indirectly via the adaptor protein importin α.30  Importin α must
first bind importin β before binding to any cargo in the cytoplasm via a nuclear
localization sequence.  Although the classical mode of nuclear import incorporates the
binding of importin β to importin α, it is also possible for importin β to bind directly to
cargo.30, 36  As fucose levels have been shown to increase during learning and memory
processes, it is possible that importin β may bind to and translocate newly fucosylated
glycoproteins into the nucleus to initiate the cellular response needed for learning.  In this
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manner, fucosylation would act as a recognition element enabling the binding of
fucosylated glycoproteins to importin β, which in turn would transport these proteins into
the nucleus.  Moreover, the transport of newly fucosylated proteins would provide direct
communication of synaptic activity to the nucleus.
In all, our studies provide new molecular-level insights into the function of L-
fucose in the mammalian brain.  We have shown that fucose-specific lectins are found in
hippocampal neurons and have made progress in identifying these specific proteins.  In
addition, we have determined that synapsin Ia and Ib are fucose-containing glycoproteins.
Taken together, our studies provide compelling evidence for an important physiological
role for fucosyl sugars in the brain.  By understanding the molecular underpinnings of
communication in the brain, we hope to ultimately provide new targets for therapeutic
intervention when learning and memory become impaired.
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Experimental Procedures for Chapter 4
Buffers and Reagents:
Chemicals and molecular biology reagents were purchased from Fisher (Fairlawn, NJ)
unless stated otherwise.  Protease inhibitors were purchased from Aldrich Chemicals (St.
Louis, MO) and Alexis Biochemicals (San Diego, CA).  Cell media was purchased from
Gibco BRL (Grand Island, NY).
Labeling of Known Fucose-Binding Lectins AAA and UEA I with Probe 2:
Purified lectins were purchased from EY Laboratories (San Mateo, CA) and used to make
1 mg/mL stocks in water.  10 µg of each lectin was incubated with or without probe 2 (1
mM) or control molecule 3 (1 mM) for 1 h at 37 °C with gentle mixing in neurobasal
media in the dark.  Samples were then irradiated on ice with UV light (365 nm) for 1 h
before resolving proteins by SDS-PAGE and analyzing by streptavidin-HRP Western
blotting and Coomassie staining.
Capture of Fucα(1-2)Gal Lectins from Dissociated Embryonic Neurons:
Embryonic brain was dissected and neurons were dissociated as described in Chapter 2.
Dissociated neurons were spun briefly (1,000 rpm, 5 min), pelleted, resuspended in
neurobasal media and incubated with probe 2 (1 mM) or molecule 3 (1 mM) for 4 h at 37
°C with gentle mixing in the dark.  Neurons were pelleted (3,000 rpm, 5 min) and washed
twice with PBS in the dark to remove any unbound probe.  Cells were resuspended in
PBS and irradiated on ice with UV light (365 nm) for 2 h.  After a brief spin (3,000 rpm,
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5 min), cells were lysed with boiling 1% SDS-containing protease inhibitors to solubilize
all proteins.  Proteins were resolved by SDS-PAGE and analyzed by streptavidin-HRP
Western blotting.
Competition Experiments Investigating Specificity of Probe 2 Labeling:
Dissociated embryonic neurons were first incubated with the competitor molecules
Fucα(1-2)Gal-OEt disaccharide, L-FucαOEt, or D-FucαOEt (each at 150 mM) for 2 h at
37 °C with gentle mixing in neurobasal media.  Probe 2 (0.3 mM) was then added and
cells were incubated for an additional 2 h in the dark at 37 °C with gentle mixing.  After
washing away unbound probe, cells were irradiated and lysed as above.  Proteins were
then resolved and analyzed by streptavidin-HRP Western blotting.
Purification of Labeled Proteins from Dissociated Embryonic Neurons:
Dissociated embryonic neurons were incubated with probe 2, irradiated and lysed as
described above. After lysis, the proteins were pre-cleared with agarose beads (Sigma)
for 1 h at room temperature to deplete agarose-binding proteins.  After a brief spin to
pellet the beads, the protein lysates were removed and incubated for 2 h at room
temperature with streptavidin-agarose beads (Pierce) in 0.2% SDS/PBS.  The streptavidin
beads were washed three times with 0.2% SDS/PBS, once with PBS, and bound protein
was eluted with 2X SDS-PAGE loading buffer containing 1000-fold excess free biotin.
Eluted proteins were resolved and probed by Western blotting as above.
88
Subcellular Fractionation and Separation by Anion Exchange Chromatography of
Dissociated Neurons Labeled with Probe 2:
Dissociated neurons were labeled with probe 2 as described above.  Cells were lysed in 5
volumes of 0.32 M sucrose/ 5 mM Tris pH 8.0 by passing through a 22-gauge needle 5
times.  The sample was diluted to 1.5 mL with sucrose buffer and passed through the
needle again another 5 times.  The cell lysate was spun at 800 x g for 10 min, supernatant
was transferred to a new tube and spun again at 16,000 x g for 15 min.  The supernatant
was saved as S2 and the pellet was saved as P2 and later lysed with boiling 1% SDS
before analysis.  The S2 fractions were measured for protein concentration using the
BCA protein assay (Pierce) and then desalted on a PD-10 column (Amersham).  The PD-
10 column was first washed with 20 mL of 50 mM Tris pH 8.0/ 0.1% Triton X-100
before adding S2 sample onto the column in a total volume of 2.5 mL.  The void volume
was discarded and protein was eluted in 3.5 mL of loading buffer.  Protein concentration
was measured again before loading desalted S2 sample onto a Q-sepharose anion
exchange column (1 mL HiTrap Q HP column; Amersham).  The Q-sepharose column
was run at a flow rate of 0.5 mL/min and was washed first with 5 column volumes of 50
mM Tris pH 8.0, then with 5 column volumes of 50 mM Tris pH 8.0/ 1 M NaCl, and then
equilibrated with 10 column volumes of 50 mM Tris pH 8.0.  The S2 sample was loaded
onto the column, washed with 5 column volumes of 50 mM Tris pH 8.0, and then
proteins were eluted with a gradient of 0 – 1 M NaCl for 20 column volumes.  Samples
were combined based on absorbance at 280 nm, concentrated and dialyzed with
Centricon filters (Millipore), and then analyzed by Western blotting and Coomassie
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staining.  Separate columns were used for cells labeled with control molecule 3 and
treated as above.
Purification of Fucα(1-2)Gal Lectins from Rat Pup Brain:
Whole cortices from rat pups were dissected as described in Chapter 3 and lysed by
sonication in ice cold binding buffer I (100 mM Tris pH 7.5, 150 mM NaCl, 1 mM CaCl2,
1 mM MgCl2, 0.5 % NP-40, 0.2% sodium deoxycholate) plus protease inhibitors and pre-
cleared over agarose beads for 1 h.  Lysates were then incubated with probe 2 or control
molecule 3 for 4 h in the dark at room temperature, followed by irradiation with UV light
for 2 h at 4 °C.  After a couple washes in binding buffer I, lysates were incubated with
streptavidin beads equilibrated in binding buffer for 2 h at room temperature.  The bead-
lysate mixture was packed into a 1 mL spin column and washed as follows: 3 column
volumes of binding buffer I, 3 column volumes of high salt binding buffer I (300 mM
NaCl), and 3 column volumes of binding buffer I without detergent.  Target lectins were
eluted with 3 column volumes of 2X SDS-PAGE loading buffer containing 1000-fold
excess free biotin, concentrated with Microcon filters (Millipore), then resolved by SDS-
PAGE and analyzed by Western blotting and silver stain.
Trypsin Digestion and MS Analysis:
Bands were excised from Coomassie-stained gels and treated essentially as described by
Shevchenko et al.37  Briefly, excised bands were destained overnight in 50% methanol/
5% acetic acid.  Destained bands were dehydrated in acetonitrile (CH3N), dried by
vacuum, and rehydrated in 10 mM DTT.  After 30 min reduction at room temperature,
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excess DTT was removed, and proteins were alkylated in 50 mM iodoacetamide for 30
min at room temperature in the dark.  After alkylation, excess iodoacetamide was
removed and protein bands were washed in 100 mM ammonium bicarbonate (NH4HCO3;
pH 8.0) for 10 min, followed by two successive dehydrations in CH3N.  Wash and
dehydration steps were repeated once more, and excess CH3N was removed under
vacuum.  Protein bands were rehydrated in 15 ng/µL trypsin (Promega) in 50 mM
NH4HCO3.  Excess trypsin solution was removed after rehydration, and 20 – 30 µL of 50
mM NH4HCO3 was then added to cover the gel slices.  Proteins were digested overnight
at 37 °C.  Following digestion, peptides were extracted with successive washes of water
followed by 50% CH3N/ 5% formic acid in water, and dried by vacuum centrifugation.
Eluted peptides were sent to our collaboraters at the Genomics Institute of the Novartis
Research Foundation (San Diego, CA) and analyzed by matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS).
Capture of UEA-I Using Multivalent Polymer 4 Affinity Column:
The known fucose-binding lectin UEA-I was used to optimize binding and capture
conditions. The Fucα(1-2)Gal affinity column was generated by incubating polymer 4 (3
mg; Glycotech Corporation) with streptavidin-agarose beads (1 mL) for 30 min at room
temperature in binding buffer I.  Unbound polymer was removed by washing with 20
column volumes of binding buffer I.  UEA-I (10 µg) was bound on the affinity column
for 4 h at room temperature followed by several wash steps (3 column volumes of
binding buffer I; 3 column volumes of high salt binding buffer I, 300 mM NaCl; and 3
column volumes of binding buffer I without detergent) and then eluting with binding
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buffer I containing 200 mM L-fucose.  Eluted samples were analyzed by SDS-PAGE and
silver staining.  UEA-I was also bound over a streptavidin column, generated as above
without polymer 4, as a control.
Capture and Purification of Fucα(1-2)Gal Lectins Using Multivalent Polymer 4:
The Fucα(1-2)Gal affinity column was generated as described above. After incubating
the samples on the column for 4 h at room temperature, the column was washed with 3
column volumes of binding buffer I, 3 column volumes of high salt binding buffer I (300
mM NaCl), and 3 column volumes of binding buffer I without detergent.  Proteins were
eluted with 3 column volumes of binding buffer I containing 200 mM L-fucose,
concentrated with Microcon filters (Millipore), then separated on Tris-acetate gels and
visualized by silver staining.  For the competition affinity column, L-fucose (1000-fold
excess) was added at the same time the sample was added to the Fucα(1-2)Gal affinity
column.
Western Blotting:
Protein concentration of samples was determined using the BCA protein assay (Pierce).
Lysates were resolved on 10% acrylamide-SDS gels.  Proteins were transferred to
polyvinylidene difluoride (PVDF) membrane (Millipore) for at least 12 h in 20 mM Tris-
Cl pH 8.6/ 120 mM glycine/ 20% methanol.  Western blots were blocked for 1 h with 3%
BSA and rinsed with TBST (50 mM Tris-Cl pH 7.4/ 150 mM NaCl/ 0.1% Tween-20).
Blots were incubated with streptavidin-HRP (1:500; Pierce) for 1 h at room temperature
with constant rocking, then rinsed and washed 4 times for 20 min with TBST.
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Immunoreactivity visualized by chemiluminescence using Pico Chemiluminescent
Substrate (Pierce).  For blots probed with Na/K ATPase and importin β antibodies, blots
were blocked in 3% BSA followed by incubation with either Na/K ATPase antibody
(1:500; Abcam) or importin β antibody (1:500; Abcam) for 2 h at room temperature.
Blots were rinsed and washed twice with TBST, followed by incubation with IRDYE680
goat anti-mouse antibody (1:5000; Rockland Immunochemicals) in TBST/0.2% SDS for
1 h at room temperature in the dark.  After 4 washes of 20 min in TBST,
immunoreactivity was visualized using the Odyssey infrared imaging system (LICOR).
Coomassie Staining:
After the proteins were resolved by SDS-PAGE, the gel was immersed in 0.1%
Coomassie/ 50% methanol/ 10% acetic acid for 30 min to 1 h at room temperature.  The
gel was then de-stained with 50% methanol/ 10% acetic acid at room temperature until
the desired contrast was obtained.
Silver Staining:
Resolved gels were fixed in 50% methanol/ 10% acetic acid for 10 min, fixed in 5%
methanol/ 1% acetic acid an additional 15 min, rinsed briefly in 50% methanol, then
washed in double distilled water (ddH2O) 3 times for 10 min each or overnight.  The gels
were then sensitized in freshly prepared sodium thiosulfite (0.02% in ddH2O) for 90
seconds exactly and rinsed in ddH2O 3 times for 30 sec each, before silver staining in
freshly prepared 0.2% silver nitrate for 30 min at room temperature or overnight at 4 °C.
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After rinsing 3 times for 60 sec each in ddH2O, the stain was developed in freshly made
6% sodium carbonate/ 0.018% formaldehyde/ 0.0004% sodium thiosulfite for up to 10
min at room temperature with constant shaking until the desired contrast was attained.
Developing was stopped in 6% acetic acid for 10 min and the gel was stored in ddH2O.
Far-Western Analysis:
Proteins were resolved by SDS-PAGE and transferred to PVDF membrane.  The blot was
blocked for 1 h at room temperature with 3% BSA in TBST.  After a few washes in
TBST, the blot was incubated with polymer 4 (13 µM in TBST) overnight at 4 °C with
gentle shaking.  After two washes of 10 min each in TBST, streptavidin-HRP (1:5000)
was added in TBST for 1 h at room temperature.  Following 4 washes of 10 min each in
TBST, immunoreactivity was visualized using Pico Chemiluminescent substrate.
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Part II—Chapter 5:  The Biological Activity of Chondroitin Sulfate
Glycosaminoglycans ∗
General functions of glycosaminoglycans
Proteoglycans are a diverse class of proteins that carry long chains of
carbohydrate polymers termed glycosaminoglycans.1, 2  Glycosaminoglycans (GAGs) are
chains of repeating disaccharide units that show tremendous structural diversity with
complex patterns of deacetylation, sulfation, length, and epimerization.3, 4  The GAG
chains are covalently bound to proteins via the hydroxyl group of specific serine residues
found in the protein core.5, 6  Proteoglycans are found in the extracellular matrix of all
tissues, including cartilage, basement membranes, and connective tissue, as well as on the
surface of most cells.  The diversity seen among the different proteoglycan families arises
from the variety of protein cores available as well as from variations in the length and
type of attached GAG chains.  Proteoglycans found in the brain are expressed under strict
control throughout nervous system development, and they act as regulators of axonal
pathfinding, cell migration, and synaptogenesis.1, 7 -- 9
Proteoglycans act as scaffold structures constructed to interact with other proteins
through noncovalent binding to their GAG chains.  In the brain, a variety of proteoglycan
families are involved in binding growth factors, cell adhesion molecules, enzymes, and
enzyme inhibitors.1  Both the syndecan and glypican proteoglycan families bind to the
neural cell adhesion molecule (NCAM), slit-1 and slit-2, which are involved in the
development of midline glia and axon pathways, different members of the fibroblast
                                                 
∗ Portions of this chapter were taken from C. I. Gama and L. C. Hsieh-Wilson (2005) Curr. Opin. Chem.
Biol. 9, 609 – 619.
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growth factor (FGF) family, and members of the Hedgehog families.2  These interactions
between the syndecan and glypican proteoglycans with their ligands are established
through the GAG bound to the protein core.
GAG chains are a family of sulfated polysaccharides involved in diverse
biological processes such as neuronal development, tumor growth and metastasis, viral
invasion, and spinal cord injury.10 -- 12  For instance, GAGs modulate key signaling
pathways essential for proper cell growth and angiogenesis.11, 12  They are also important
for axon pathfinding in the developing brain and have been linked to the pathology of
Alzheimer’s disease.13, 14  Potentially, GAGs and their associated protein cores can recruit
protein ligands to the cell surface and mediate the binding of ligands to their
corresponding receptors (Figure 5.1).15, 16  The remarkable ability of GAGs to regulate
various processes is only beginning to be understood at a molecular level.  Increasing
evidence suggests that GAGs encode information in the form of a ‘sulfation code.’
Namely, discrete sulfation motifs along the carbohydrate backbone carry instructions to
direct proteins and regulate complex processes such as neuronal wiring.  Deciphering this
code and the mechanisms by which it coordinates biological events is critical for
understanding diverse aspects of biology and may reveal new therapeutic opportunities.
Figure 5.1.  One proposed mechanism of GAG function at the cell
surface
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Structural diversity of glycosaminoglycans
GAGs are composed of repeating disaccharide subunits that are assembled into
linear polysaccharide chains (Figure 5.2).  These polysaccharides are often covalently
attached to proteins (proteoglycans) at the cell surface or in the extracellular matrix.
There are several major classes of GAGs, including heparan sulfate/heparin, chondroitin
sulfate, dermatan sulfate, and keratan sulfate, which differ in their core disaccharide
subunit.  Heparan sulfate (HS) and heparin contain D-glucosamine (GlcN) and either D-
glucuronic acid (GlcA) or L-iduronic acid (IdoA) subunits joined via α(1,4) and β(1,4)
linkages.  Chondroitin sulfate (CS) has N-acetylgalactosamine (GalNAc) and GlcA
subunits and alternating β(1,3) and β(1,4) linkages.
Figure 5.2. Structures of representative classes of GAGs
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The biosynthesis of HS and CS occurs in the Golgi apparatus and starts with the
generation of the tetrasaccharide linkage region, GlcA-β(1,2)-galactose-β(1,2)-galactose
β(1,4)-xylose β-1-O-Ser (Figure 5.3).  Xylose is first linked to select proteoglycan core
protein serines, followed by the addition of two galactose residues and a GlcA moiety.17,
18  The next residue added determines whether the GAG will be either HS/heparin or CS.
Addition of N-acetylglucosamine (GlcNAc) commits the biosynthesis to HS/heparin
while addition of N-acetylgalactosamine (GalNAc) gives rise to CS.  The HS/heparin
chain is elongated by the EXT1 and 2 polymerases, which add alternating GlcA and
GlcNAc residues joined by alternating α(1,4) and β(1,4) linkages.18    The CS chain,
elongated by the CS polymerases, consists of alternating units of GlcA and GalNAc
linked through β(1,3) and β(1,4) bonds.19, 20
Diverse sulfation patterns are generated in vivo through extensive modification of
the growing GAG chains (polysaccharides).10  The polysaccharides are modified in the
Golgi apparatus by sulfotransferases, deacetylases, and epimerases.2  The precise
mechanisms for generating such diverse sulfation patterns is not known.  However, it is
thought that the enzymes may form complexes in the Golgi apparatus and influence each
others’ activity.  The sulfotransferases add sulfate groups from 3’ phosphoadenosine-5’
phosphosulfate (PAPS).  There have been fifteen HS/heparin sulfotransferases identified
from mice and humans and the first sulfotransferase to modify HS/heparin chains is N-
deacetylase-N-sulfotransferase (NDST), a bifunctional enzyme which deacetylates and
subsequently sulfates the C2 amine of GlcNAc.4, 21, 22  Following N-sulfation, some of the
GlcA residues in the HS/heparin chains can be converted to IdoA by the C-5 epimerase.
Sulfation can then occur at the C2 hydroxyl of IdoA and GlcA, the C3 hydroxyl of GlcN,
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and the C6 hydroxyl of GlcN.23 -- 29  Although HS and heparin are structurally related, HS
has greater overall chemical complexity, exhibiting more varied sulfation patterns, lower
IdoA content, and longer polysaccharide chains.3, 10  Furthermore, HS is ubiquitously
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Figure 5.3.  Biosynthesis of HS/heparin and CS GAGs takes place in the Golgi apparatus.
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expressed in vivo and has a broader range of physiological targets than heparin, which is
primarily localized to specialized granule cells.
Diverse sulfation motifs are also found on CS, with sulfation occurring at each of
the free hydroxyls.30  The CS sulfotransferases can be categorized into three major
groups: 1) those which add sulfate groups to the C4 hydroxyl of GalNAc, 2) those adding
sulfate groups to the C6 hydroxyls of GalNAc, and 3) those adding sulfate groups to the
C2 hydroxyl of GlcA.4  To date, there have been seven CS sulfotransferases identified.
Sulfation of the C4 hydroxyl on GalNAc generates the CS-A pattern while sulfation of
the C6 hydroxyl on GalNAc affords the CS-C pattern, the two most common motifs
found in vivo.31  These two motifs can be further sulfated at the C6 hydroxyl of GalNAc
and the C2 hydroxyl of GlcA to generate the CS-E and CS-D pattern, respectively
(Figure 5.4).
The variety of sulfotransferases found in vivo produces multiple sulfation motifs
and patterns, generating the extraordinary amount of structural complexity observed in
HS and CS GAGs.  A simple tetrasaccharide of CS has the potential to encode 256
sulfation sequences, while an HS tetrasaccharide, which has greater complexity due to the
Figure 5.4. Structures of the most common CS sulfation motifs found in vivo
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presence of IdoA and N-sulfation, can display over 2000 sulfation motifs.  Although it
remains to be seen whether all of these possible sulfation patterns occur in vivo, a large
number of distinct sulfated structures have been identified to date.10, 30
 On a macromolecular level, HS and CS polysaccharides exhibit various chain
lengths (~ 10 to 100 disaccharide units) and clustered regions of high or low sulfation
(Figure 5.5).10  Structural studies have shown that GAGs adopt helical structures whose
pitch may vary with the associated counterion.32, 33  Moreover, the conformational
flexibility of the pyranose ring of IdoA, which exists in equilibrium between different
chair and skew-boat conformations when sulfated at the C2 position, has been postulated
to enhance the specificity of HS for its protein targets.10  Thus, the combination of
sequence, charge distribution, sugar conformation, and three-dimensional structure
endows GAGs with rich structural diversity.
Figure 5.5. Heterogeneous GAG polysaccharides exhibit areas of low and high sulfation.
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The potential sulfation code of HS and CS glycosaminoglycans
Evidence suggests that the chemical diversity of GAGs serves essential functions
in vivo. Genetic studies have established the importance of GAGs and the various
sulfotransferases that decorate the carbohydrate backbone.  For instance, conditional
knock-out mutants of the HS polymerizing enzyme EXT1 display severe CNS defects
with a complete loss of olfactory bulbs, abnormally small cerebral cortices, and an
absence of major commissural tracts.34  Similarly, reducing the levels of the CS
polymerizing enzyme in C. elegans resulted in decreased levels of cell surface CS and
caused a reversion of cytokinesis, where cells were unable to divide and eventually
died.35  Deletion of 2-O-sulfotransferase activity in worms caused cell migration defects36
while 2-O-sulfotransferase-deficient mice displayed a significant decrease in cell
proliferation in the developing cerebral cortex37.  Furthermore, mutation of the N-
deacetylase/N-sulfotransferase gene in Drosophila inhibited growth factor signaling and
disrupted embryonic development.38  Together, these studies indicate an essential
requirement for GAGs and their modifying enzymes during development.
Consistent with their essential roles, the sulfation patterns of GAGs are tightly
regulated in vivo.  Distinct sulfated forms are associated with particular tissues,
developmental stages, and disease states.  For instance, 2-O-sulfotransferase null mice
present complete failure of kidney development24, 39 while 6-O-sulfotransferase deficient
flies exhibit embryonic lethality and disruption in initial branching of the tracheal
system.40  Additionally, differentially sulfated CS motifs are localized to specific brain
regions and found along axonal growth tracts.41, 42  The sulfation patterns of HS and CS
are also altered during embryonic brain development, as are specific sulfotransferase
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activities.43, 44  Moreover, distinct HS motifs have been linked to the development of
several diseases, including the pathology of Alzheimer’s disease and cancer metastasis.12,
14
The molecular mechanisms by which GAGs contribute to these biological events
are only beginning to be understood.  However, many studies suggest that GAGs
coordinate complex processes by regulating the activities of growth factors and other
target proteins.  The four main HS proteoglycan core proteins found in the nervous
system are syndecans, glypicans, perlecan, and agrin.1  In addition to modifying the
above proteins, HS can bind a large variety of proteins found on the cell surface and in
the extracellular matrix as well as potentiate the activity of secreted proteins.
One of the most studied examples is the binding of HS to the fibroblast growth
factors (FGFs).  The FGFs comprise a large family of growth factors (23 members to
date) and have been shown to play critical roles in morphogenesis, development,
angiogenesis and wound healing.45  They activate signaling pathways by inducing the
dimerization of tyrosine kinase receptors (FGFRs).  Two distinct models have been
proposed to explain the essential contribution of HS to FGF-FGFR signaling.  A crystal
structure of the HS-FGF2-FGFR1 complex obtained by Schlessinger, Mohammadi, and
co-workers suggests that two ternary complexes of HS-FGF-FGFR come together with
the non-reducing ends of each sugar chain facing one another upon activation (Figure
5.6A).33  In contrast, the HS-FGF1-FGFR2 structure of Pellegrini, Blundell, and co-
workers suggests that a single HS chain initiates the assembly of two FGF-FGFR
complexes (Figure 5.6B).46  Although these models propose distinct roles for HS in
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coordinating receptor dimerization, both agree on the formation of an activated FGF-
FGFR-HS complex.
Importantly, the specific sulfation pattern of HS appears to be critical for binding
to FGF and assembly of the complex.  Structural analyses have shown that many of the
interactions between HS/heparin and the FGFs involve salt bridges and hydrogen-
bonding contacts between the sulfate and carboxylate groups of the oligosaccharide with
polar residues on FGF.47  Optimal van der Waals contacts and the flexibility of HS chains
may further enhance the interaction.48  Interestingly, none of the residues in the heparin-
binding region, including the polar side chains, are completely conserved throughout the
FGF family.47  This raises the intriguing possibility that variations in HS sequence or
sulfation pattern might specify the binding of particular FGFs, allowing for the selective
activation of signaling pathways.  Consistent with this view, biochemical studies have
shown that FGF-2 requires 2-O-sulfation, but not 6-O-sulfation, for HS binding, whereas
FGF-10 has the reverse preference, and FGF-1 requires both 2-O-sulfation and 6-O-
sulfation.49  Distinct sulfation preferences are also exhibited by the FGFRs; for instance,
Figure 5.6.  Crystallographic models of the FGF-FGFR-HS complex. A) The crystal structure of an
FGF2-FGFR1-heparin complex has a 2:2:2 stoichiometry with two chains enabling complex formation.
B) The crystal structure of an FGF1-FGFR2-heparin complex has a 2:2:1 stoichiometry with a single
chain initiating complex formation.
A
FGF
FGFR
HS
B
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6-O-sulfation was required for FGFR2 IIIb but not FGFR1 activation.50  Unfortunately,
the heterogeneity of biochemical HS preparations has made it difficult to examine
specific sulfation sequences.  It is anticipated that homogeneous oligosaccharide libraries
of defined sequence will provide additional insights into the importance of the sulfation
code.  Resolution of the code and precise activation mechanism will be critical for
understanding growth-factor signaling and may reveal common mechanistic themes
utilized by both HS and CS GAGs.
Recent studies have also revealed striking roles for GAGs and their sulfation
patterns during neuronal development.  Axons are guided to their target locations by
diffusible and cell-surface-bound cues that either attract or repel the growing tip of the
axon. One such cue is the cheomotropic axon guidance molecule Slit.  Slit proteins can
bind several different receptors and act as a chemorepellent signal for appropriate axon
growth.  Several studies have shown that HS is essential for Slit binding to its receptors.
Removal of HS by heparinase treatment abolished Slit binding to glypican-1 and Robo.51,
52 Absence of cell surface HS also altered Slit activity and prevented repulsion of
migrating olfactory neurons and growing olfactory bulb axons.51  Further evidence for the
importance of HS in axonal guidance comes from mutants completely lacking HS in the
developing brain.  Conditional knock-out mutants of the HS polymerizing enzyme EXT1
displayed severe CNS defects.34  Similar mutants in C. elegans also display severe
developmental defects.53
In related studies, Bülow and Hobert used genetic approaches to probe the role of
HS sulfation in axon guidance.13  Abolishing the activity of three HS modifying enzymes,
C-5 epimerase, 2-O-sulfotransferase, and 6-O-sulfotransferase, in C. elegans revealed
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that particular neuron types require specific HS motifs for normal growth.  Some axons
required all three modifying enzymes, others required either C-5 epimerase or 2-O-
sulfotransferase activity, and still other neuron types did not require any of the enzymes.
These studies support the idea that distinct modifications to HS structure are essential for
neuronal development and may encode instructions that guide neurons to their proper
targets in vivo.
Along with HS, CS has been shown to be an important factor for neuronal
development and axon guidance.  Reducing levels of the CS polymerizing enzyme in C.
elegans resulted in decreased levels of cell surface CS and caused a reversion of
cytokinesis, where cells were unable to divide and eventually died.35  Treatment of
normal embryonic cells with chondroitinase ABC also caused incomplete cytokinesis,
thus indicating a crucial role for CS in embryonic development.54
In the central nervous system, CS mainly acts as a barrier-forming molecule and
there are many examples of such boundaries to growing axons. In the notochord, there
are high levels of CS preventing axon extension.55  Removal of CS with chondroitinase
leads to misguided growth of embryonic motor nerves and dorsal root ganglion axons.  In
the optic pathway, CS prevents retinal axons from growing to the outer parts of the retina
and guides them directly towards the optic nerve.56   Retinal axons will grow randomly,
however, upon treatment with chondroitinase.  High levels of CS are also found in glial
scars formed after injury to the CNS and are one of the main obstructions to axon
regeneration.  As detailed in the above studies, removal of CS abolishes the axon-growth
barrier and thus can be a useful strategy to treat axon growth inhibition following CNS
injury in vivo.  Indeed, several studies have used chondroitinase treatment to regenerate
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growth of dopaminergic neurons following nigrostriatal tract lesion as well as regrowth
of sensory and motor axons after dorsal column lesions.57, 58
Despite the studies demonstrating inhibitory roles of CS on axon growth, there are
contrasting studies showing stimulatory roles of CS on neurite growth.  CS molecules
with particular oversulfated structures (E and D motifs) enhance the outgrowth of
hippocampal neurons as well as enable binding of particular growth-promoting receptors
to their ligands (PTPζ  or phosphacan to midkine and pleitrophin).59 -- 62  CS
polysaccharides enriched in the CS-C and CS-D motif have also been shown to promote
the growth of mesencephalic dopaminergic neurons.59, 63, 64  Moreover, CS has been
associated with axonal growth tracts in the developing brain and thalamic neurons.41, 65, 66
In all, the above studies underscore the importance of GAG structure in regulating
critical biological processes. The molecular diversity of GAGs may provide a powerful
means to influence complex signaling pathways in vivo.  The spatial and temporal
regulation of HS and CS modifications could facilitate or inhibit ligand-receptor
interactions in a highly localized manner.  With the considerable diversity that exists in
HS and CS chains, the sulfation code would represent an elegant means of molecular
level control.  It will be exciting to discover the extent to which Nature utilizes this
potential.
Deciphering the sulfation code using chemistry
Deciphering the sulfation code will require the development of new strategies for
manipulating and evaluating specific GAG structures.  At present, there are no methods
for the rapid identification of biologically active sulfation motifs.  Genetic and
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biochemical approaches have established critical roles for GAGs in particular biological
contexts.  However, deletion of a sulfotransferase gene leads to global changes
throughout the carbohydrate chain, making it difficult to pinpoint the impact of a specific
structural motif.  GAGs have also been isolated from natural sources, but their structural
complexity and heterogeneity are a significant limitation.  The presence of multiple
sulfation motifs in biochemical preparations complicates efforts to attribute a biological
function to a specific sulfation motif.  Moreover, studies with purified natural GAGs are
biased toward abundant, readily isolable sequences.  As such, it can be difficult to study
physiologically important sulfation patterns that are present in low cellular abundance.
Chemical approaches provide a powerful solution to these challenges.  Virtually
any desired GAG structure can be generated using synthetic chemistry, with exquisite
control over stereochemistry, length, and pattern of sulfation.  Access to homogeneous,
well-characterized structures facilitates the identification of biologically active sequences
and enables systematic investigations into structure-activity relationships.  As such, our
research combines synthetic chemistry with neurobiology to enable the elucidation of the
sulfation code of CS in the brain.  We seek to generate the first synthetic library of well-
defined CS oligosaccharides containing various sulfation sequences in order to evaluate
and assign specific functions to distinct CS motifs.  The ability to obtain defined GAG
structures and related analogues should also accelerate investigations into the therapeutic
potential of GAGs, in areas such as cancer biology, neurobiology, and virology.
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Chapter 6: Investigations into the Sulfation Code of Chondroitin Sulfate
Glycosaminoglycans ∗†
Background
Chondroitin sulfate glycosaminoglycans are sulfated polysaccharides implicated
in cell division, neuronal development, and spinal cord injury.1 -- 3 While considerable
attention has been focused on heparan sulfate (HS) glycosaminoglycans, much less is
known about the chondroitin sulfate (CS) class.  As with all glycosaminoglycans
(GAGs), the complexity and heterogeneity of CS has hampered efforts to understand its
precise biological roles.  For instance, CS has been shown to prevent the growth of
axons; yet it is also found in developing, growth-permissive regions.1, 4 Synthetic access
to CS molecules of defined length and sulfation pattern, in combination with biological
studies, should enable a systematic examination of structure-activity relationships.
Although GAGs exist as a heterogeneous mix in nature, several studies have
shown that specific sulfation sequences direct the activity of both HS and
CS.  In fact, it is now thought that GAG activity is dictated by a sulfation code where
distinct sulfation patterns are spatially and temporally regulated and direct the biological
activity of HS and CS GAGs.  For example, mutational deletion of HS 2-O -
sulfotransferase activity disrupted development of both the kidney and cerebral cortex,5 -- 7
                                                 
∗ Synthesis of all of the chondroitin sulfate oligosaccharides was carried out by Dr. Sarah E. Tully, Dr.
Sherry Tsai, Dr. Ross Mabon, and Dr. Manish Rawat, former graduate students and postdoctoral scholars in
the Hsieh-Wilson laboratory.  Biological studies using dopaminergic neurons were carried out by Naoki
Sotogaku, a graduate student in Akinori Nishi’s laboratory in the Department of Pharmacology at the
Kurume University School of Medicine, Kurume, Fukuoka, Japan.
† Portions of this chapter were taken from S. E. Tully et al. (2004) J. Am. Chem. Soc. 126, 7736 – 7737 and
C. I. Gama et al. (2006) Nat. Chem. Biol. 2, 467 – 473.
119
while 6-O-sulfotransferase activity was necessary for muscle differentiation and proper
tracheal development.8, 9  Growth factors also display preferential binding to distinct
sulfation sequences; for instance, FGF-2 requires 2-O-sulfation but not 6-O-sulfation of
HS and both pleiotrophin and midkine were shown to preferentially bind CS enriched in
the disulfated CS-E motif.10, 11  Distinct sulfation patterns of CS have also been shown to
influence neuronal growth, as both a stimulatory and inhibitory cue.1, 12, 13
Advancing a molecular-level understanding of GAGs will require new tools for
studying their structure-function relationships.  Although several strategies have been
developed, there are currently no methods to systematically explore the role of specific
sulfation sequences.  For instance, genetic approaches that target a particular
sulfotransferase gene perturb many sulfation patterns throughout the polysaccharide
chain and therefore cannot be used to study the impact of a single structural motif.14, 15
Biochemical methods afford a mixture of heterogeneously sulfated compounds of poorly
defined linear sequence,16 thereby complicating efforts to relate a biological function to a
particular sulfation sequence.
We have developed a chemical approach to evaluate the structure-activity
relationship of CS as it effects neuronal growth.  Through the synthesis of
oligosaccharides of defined length and sulfation pattern, we have demonstrated that the
CS-E sulfation sequence is a stimulatory motif that promotes the growth of hippocampal,
dorsal root ganglion, and dopaminergic neurons.
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CS-E sulfated tetrasaccharide enhances neurite outgrowth
CS polysaccharides have been shown to both stimulate and attenuate the growth
of cultured neurons.17 -- 19  Notably, the molecules used in those studies were ~ 200
saccharides in length, poorly defined, and heterogeneously sulfated, features that might
account for the contradictory observations.  Therefore, we sought to investigate the
biological properties of CS-E and establish the minimal structural determinants needed
for activity.  Toward this end, di- and tetrasaccharides bearing the CS-E sulfation pattern
were first synthesized by Dr. Sarah E. Tully, Dr. Sherry Tsai, Dr. Ross Mabon, and Dr.
Manish Rawat (Figure 6.1).20
To explore the ability of compounds 6 – 8 to modulate neuronal growth, we
cultured primary hippocampal neurons with or without each compound.  After a 48 h
treatment, the neurons were fixed, immunostained with anti-tau antibodies, and examined
Figure 6.1. Structures of the initial synthetic CS oligosaccharides
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by fluorescence microscopy.  Sulfated tetrasaccharide 8 exhibited striking effects on
neuronal morphology and growth (Figure 6.2).20  The growth of the major neurite
extension was dramatically stimulated by 39.3 ±  3.6% relative to the untreated,
polyornithine control.  In contrast, sulfated disaccharide 6 and unsulfated tetrasaccharide
7 had no significant effect on neuronal outgrowth.
These results indicate that a tetrasaccharide represents a minimum structural motif
with biological activity and that sulfation is necessary for function.  Moreover, these
studies are the first, direct investigations into the structure-activity relationships of CS
Figure 6.2.  CS-E tetrasaccharide 8  stimulates the outgrowth of hippocampal neurons. A)
Immunofluorescence images of neurons 48 h after treatment with the indicated compound. B) Statistical
analysis of neurite length.  P value is relative to poly-ornithine control.  Scale bars represent 45 µm.
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using homogeneous, synthetic molecules.  The ability of CS small molecules to
recapitulate the activity of larger, natural polysaccharides provides a new chemical
approach to understand and manipulate neuronal growth and regeneration.
The CS-E sulfation pattern is a stimulatory motif that enhances neurite outgrowth
Once we established that a tetrasaccharide was a minimum structural determinant
displaying biological activity, we proceeded to evaluate the sulfation code hypothesis for
CS function.  Several tetrasaccharides representing three important subclasses of CS
found in vivo were then synthesized by Dr. Sarah E. Tully, Dr. Ross Mabon, and Dr.
Manish Rawat (Figure 6.3).21  Tetrasulfated molecule 8 contains the CS-E sulfation
sequence.  Disulfated molecules 9 and 10 represent the most abundant sulfation patterns
found in vivo, CS-A and CS-C, respectively.22  For comparison, we also generated two
unnatural CS molecules, tetrasulfated molecule 11, denoted CS-R, and a dimer of CS-E
disaccharides (molecule 12).  These two molecules have not yet been isolated from
natural sources, however they represent important controls because they possess the same
overall negative charge as CS-E tetrasaccharide 8, unlike molecules 9 and 10, which are
only disulfated, not tetrasulfated.  Moreover, these control molecules display the negative
charge in a different manner and will further elucidate whether the specific placement of
the sulfate groups, and not just the overall charge, is crucial for biological activity of the
CS molecules.
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To compare the neuritogenic activity of the differentially sulfated
tetrasaccharides, we cultured hippocampal neurons on coverslips coated with
polyornithine and each compound.  After 48 h, the neurons were fixed, immunostained
with antibodies to tubulin, and then examined by fluorescence microscopy.  A specific
sulfation pattern was required for the growth-promoting activity of CS.  As shown in
Figure 6.4, the CS-E tetrasaccharide was the only molecule that stimulated neurite
outgrowth.21  Following quantitation of neuronal growth and comparison to untreated
controls, we found that the CS-E tetrasaccharide stimulated neurite outgrowth by 48.6 ±
2.3%, while tetrasaccharides representing CS-A and CS-C motifs had no appreciable
activity (Figure 6.4).  Importantly, CS-R and the dimer had no effect on neurite
outgrowth, despite having the same overall negative charge as CS-E.  These results are
consistent with previous studies reporting that CS polysaccharides enriched in the CS-E
sulfation pattern posses neuritogenic activity.16  However, it is important to note that in
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Figure 6.3.  Structures of synthetic CS oligosaccharides containing distinct sulfation patterns
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those studies the CS polysaccharides used were heterogeneous and contain variations in
size and, significantly, in the sulfation patterns present.  It is therefore possible that other
sulfation patterns present could have contributed to the reported effects.  Our results
further extend those findings and establish conclusively for the first time that it is the
precise placement and orientation of the sulfate groups that determines the biological
activity of CS.  Moreover, our studies indicate that the CS-E sulfation motif is
responsible for the growth-promoting effects observed.
We next investigated whether the effects of the CS-E motif are unique to specific
cell types.  Paradoxically, CS has been reported both to stimulate and inhibit neuronal
Figure 6.4.  The sulfation pattern directs the neuritogenic activity of CS. A) Representative
immunofluorescence images of neurons cultured on a substratum of polyornithine and the synthetic
molecules. B) Quantification of neurite length, expressed as percentage growth relative to polyornithine
control. *P < 0.0001, relative to polyornithine control.
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growth, depending on the cellular context. For example, CS proteoglycans can repel
migrating neurons or extending axons during brain development or after injury.1, 13
However, CS staining was also found to coincide with developing axon pathways, and
tissues expressing CS do not always exclude axon entry.23  To examine whether sulfation
is important for the growth of other neuron types, we cultured dorsal root ganglion
(DRG) neurons from rat embryos on a substratum of each tetrasaccharide.  DRG neurons
are a good model for investigations into the effects of CS on spinal cord neuron growth.
We found that the CS-E tetrasaccharide had a similar activity toward both DRG and
hippocampal neurons, where the outgrowth of DRG neurons was stimulated by 32.5 ±
2.9% (Figure 6.5A).21  In contrast, the CS-C, CS-A, CS-R, and dimer motifs showed no
appreciable activity.  In a similar manner, our collaborator Naoki Sotogaku found that
dopaminergic neurons were stimulated by the CS-E tetrasaccharide but not the other
sulfation patterns (Figure 6.5B).21  Dopaminergic neurons are derived from the
mesencephalon and are the neurons affected in Parkinson’s disease, schizophrenia and
attention deficit/hyperactivity disorder.24  The ability of the CS-E sulfation motif to elicit
a response in various cell types suggests that protein receptors, which can be shared by
many cell types, are likely present to engage the carbohydrate.  These results indicate that
the molecular structure of CS GAGs is critical for the function of CS, largely independent
of neuron type.
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Discussion
Together, our studies provide compelling support for the existence of a sulfation
code, whereby the precise position of sulfate groups along the carbohydrate backbone
permits GAGs to encode information in a sequence-specific manner.  Using well-defined
oligosaccharides, we have directly shown that distinct CS sulfation sequences stimulate
neuronal outgrowth.  Moreover, the activity of CS-E relative to other CS subclasses, CS-
R and the dimer, as well as the preservation of activity across different cell types,
suggests the importance of specific molecular interactions rather than nonspecific,
electrostatic effects.  HS has also been proposed to operate through a sulfation code,15 and
the concept of a sulfation code finds precedent in the sequence-specific manner in which
other biopolymers (DNA, RNA and proteins) interact with their molecular targets.
According to the sulfation code hypothesis, chemical modifications to the
polysaccharide backbone may be introduced in a time- or region-specific manner, such as
during development or in response to injury.  Precise modifications to GAGs could
facilitate or inhibit ligand-receptor interactions in a highly localized fashion, providing an
Figure 6.5. The CS-E sulfation motif stimulates the outgrowth of DRG (A) and dopaminergic neurons
(B). Neurons were cultured for 2 – 5 days on coverslips coated with polyornithine and the
tetrasaccharides at the indicated concentrations. Neurite length is expressed as percentage of growth
relative to polyornithine control. *P < 0.0001, relative to polyornithine control.
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exquisite means for regulatory control.  Specific sulfation motifs could control the
diffusion and efficient signaling of growth factors, establishing concentration gradients
and boundaries.  Indeed, support for this view can be seen in Drosophila melanogaster
mutants where HS biosynthesis was shown to be essential for Hedgehog signaling during
embryonic patterning.25  Furthermore, specific CS sulfation motifs are upregulated during
neuronal development and are enriched along axon growth tracts.26
The ability of the CS-E tetrasaccharide to stimulate neuronal outgrowth of various
cell types suggests that CS GAGs are involved in directing neuronal growth during
nervous system development. Indeed, our findings support previous studies implicating
the CS-E motif in the growth and development of neurons.  For instance, CS-E is found
on the protein appican, an isoform of the amyloid precursor protein that exhibits
neurotrophic activity.27  Moreover, the CS-E motif has been shown to be enriched in the
developing brain and is crucial for axonal guidance of growing neurons.13, 22, 23, 28  With
the finding that distinct sulfation patterns display biological activity, it is now necessary
to examine how these motifs elicit such responses in neurons.  As such, we proceeded to
investigate the mechanism by which the CS-E motif induces neuronal outgrowth and to
examine which proteins are being recruited and activated by the carbohydrate.
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Experimental Procedures for Chapter 6
Buffers and Reagents:
Chemicals and molecular biology reagents were purchased from Fisher (Fairlawn, NJ)
unless stated otherwise.  Cell culture media was purchased from Gibco BRL (Grand
Island, NY).  German glass coverslips were purchased from Carolina Biologicals
(Burlington, NC).
Neuronal Cultures:
Hippocampal neuronal cultures were prepared from embryonic rats as described in
Chapter 2.  DRG cultures were prepared from the spinal cord of E18 embryos of
Sprague-Dawley rats.  We dissected ganglia in Calcium- and Magnesium-Free Hank’s
Balanced Salt Solution (CMF-HBSS; Gibco), digested them with 0.25% trypsin (Gibco)
for 20 min at 37 °C and dissociated the resulting fragments in culture medium consisting
of DMEM-F12, 10% horse serum, N2 supplement, and nerve growth factor (50 ng/mL).
We plated DRG neurons at 100 cells/mm2 on coverslips coated with polyornithine and
the tetrasaccharides.
Preparation of Coverslips:
German glass coverslips (15 mm) were first sterilized by successive washes in ethanol
and water.  Specifically, coverslips were dropped one at a time into 95% ethanol, swirled
around, then washed twice with double-distilled H2O.  A final rinse with 100% ethanol
was added before allowing the coverslips to dry in the sterile tissue culture hood.
Coverslips were then coated as described by Clement et al.12  Briefly: coverslips were
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precoated with 0.015 mg/mL poly-DL-ornithine (in 10 mM Borate buffer pH 8.1; Sigma)
for 1 h at 37 °C/ 5% CO2, washed three times with double-distilled H2O, and coated with
0.05 to 0.5 mg/mL of compounds 6 – 11 in PBS (100 µL) overnight at 37 °C/ 5% CO2.
The coverslips were then washed three times with PBS and flooded with culture media
until neurons were ready to be plated.  Notably, the use of adhered compounds to glass
coverslips has been reported to simulate the extracellular matrix, and the procedure by
Clement et al. was used previously to implicate heterogeneous polysaccharides
containing the CS-E motif in neuronal growth.
Calibration of CS Molecules:
The relative concentrations of the CS oligosaccharides were calibrated to one another
using the carbazole assay for uronic acid residues.29  Briefly, the acid borate reagent (1.5
mL of a solution of 0.80 g sodium tetraborate, 16.6 mL H2O, and 83.3 mL sulfuric acid)
was added to glass vials.  The oligosaccharides were added (50 µL of a 10 mg/mL stock
in H2O) and the solution placed in a boiling H2O bath for 10 min.  Following addition of
the carbazole reagent (50 µL of 0.1% w/v carbazole in 100% ethanol), the solution was
boiled for 15 min.  The absorbance was read at 530 nm and compared to a D-
glucuronolactone standard in H2O.
Immunocytochemistry of Neuronal Cultures:
After 48 h in culture, neurons on coverslips were fixed and treated for immunostaining as
described in Chapter 2.  Neurons were immunostained with anti-tau antibodies (rabbit
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polyclonal, 1:600; Sigma) or anti-β-tubulin III antibodies (mouse monoclonal, 1:500;
Sigma) and were examined by confocal fluorescence microscopy.
Confocal Fluorescence Microscopy:
All cells were imaged on a Zeiss Axiovert 100M inverted confocal laser microscope in
the Biological Imaging Center in the Beckman Institute at Caltech.  The images were
captured with LSM Pascal software using a 40X plan-neofluar oil objective.  Cells were
excited with 488 nm light.
Morphometric analysis:
For quantitative analysis, 50 cells were analyzed per coverslip and each treatment was
performed in triplicate.  The neurite length is expressed as the total length of the neurite
from the perikarya, and only cells with neurites longer than one cell body diameter were
counted, as per standard protocol.  The length of the longest neurite was measured using
NIH Image 1.62 software.  The mean neurite lengths were compared among the different
substrate conditions with the ANOVA test followed by the Scheffe test using the
statistical analysis program StatView (SAS Institute Inc.) and Kaleidograph (Synergy
Software).
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Chapter 7: Elucidating the Mechanism of CS-E Mediated Neuronal Outgrowth ∗†
Background
Glycosaminoglycans (GAGs) have an inherent capacity to encode functional
information that rivals DNA, RNA, and proteins.  Specifically, these polysaccharides
display diverse patterns of sulfation that are tightly regulated in vivo.1, 2  Over the past
several decades, genetic and biochemical studies have established the importance of
GAGs in regulating many physiological processes, including morphogenesis and
development, viral invasion, cancer metastasis and spinal cord injury.3 -- 6  However, a key
unresolved question is whether GAGs utilize specific sulfation sequences to modulate
biological processes.
Chondroitin sulfate (CS) GAGs have been shown to play critical roles in various
physiological processes, ranging from cell division to spinal cord injury.6, 7  The
complexity of these polysaccharides has hindered efforts to relate structure to function
and to generate defined molecular tools for manipulating CS activity.  Comprising 40 –
200 sulfated disaccharide units, CS is thought to contain “blocks” of high and low
sulfation, with highly sulfated regions serving as binding sites for growth factors,
cytokines, and other proteins.8 -- 11  For instance, several growth factors, including
midkine, pleiotrophin, and FGF-16, exhibit preferential binding to highly sulfated CS
                                                 
∗ Synthesis of all of the chondroitin sulfate oligosaccharides was carried out by Dr. Sarah E. Tully, Dr.
Sherry Tsai, Dr. Ross Mabon, and Dr. Manish Rawat, former graduate students and postdoctoral scholars in
the Hsieh-Wilson laboratory.  The CS-E glycopolymers were synthesized by Dr. Manish Rawat.
Computational modeling studies were performed by Peter M. Clark, a graduate student in the Hsieh-Wilson
laboratory.
† Portions of this chapter were taken from C. I. Gama et al. (2006) Nat. Chem. Biol. 2, 467 – 473 and M.
Rawat et al. (2008) J. Am. Chem. Soc. 130, 2959 – 2961.
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polysaccharides containing either CS-E or CS-D sulfation patterns.12, 13  Furthermore, the
highly sulfated CS-E polysaccharide has been shown to antagonize the activity of the
proinflammatory cytokine TNFα  as well as activate phospholipase C signaling in
dopaminergic neurons.14, 15
Although GAGs contribute to diverse physiological processes, an understanding
of their molecular mechanisms has been hampered by the inability to access
homogeneous GAG structures.  As described in Chapter 6, we assembled well-defined
CS oligosaccharides with sulfate groups installed at precise positions along the
carbohydrate backbone.  Using these defined structures, we demonstrated that distinct
sulfation patterns modulate neuronal growth.  Specifically, we have shown that the CS-E
motif enhances neuronal outgrowth of hippocampal, dorsal root ganglion, and
dopaminergic neurons.9, 16  Here, we extend these studies to examine how specific
sulfation motifs function as molecular recognition elements for growth factors and
investigate the mechanism by which the CS-E sulfation pattern stimulates neuronal
outgrowth.
The CS-E sulfation motif regulates neuronal outgrowth
CS GAGs have been shown to influence neuronal growth as both a stimulatory
and inhibitory cue.6, 17, 18  These conflicting effects are most likely due to the
heterogeneity of the polysaccharides employed in these studies.  However, it is also
possible that inconsistent experimental designs and the examination of differing cell
types may contribute to the opposing effects observed.  Our initial studies demonstrated
that the CS-E motif specifically stimulates neuronal growth across various neuron types
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(Chapter 6).  In an attempt to resolve the paradoxical nature of CS, we used CS-E-
enriched polysaccharides to modulate the growth of hippocampal neurons.  First, we
grew hippocampal neurons on a substratum of polyornithine in the presence or absence of
CS-E polysaccharide.  Consistent with previous studies,19 we saw that neuronal
outgrowth was dramatically stimulated by treatment with CS-E polysaccharide (Figure
7.1).  Importantly, the enhanced neuronal outgrowth was specific to the polysaccharide,
as treatment with chondroitinase ABC, an enzyme that digests CS, abolished the
stimulatory effects observed.  These results suggest that CS-E polysaccharide present on
the surface is presumably interacting with growth factors in the culture media and thus
enabling activation of neuronal growth pathways.
To systematically examine the mechanism of CS-E-mediated neuronal growth, we
then presented the polysaccharide to the cells in solution.  Interestingly, soluble CS-E
polysaccharide caused dramatic inhibition of neurite outgrowth (Figure 7.2).  Although
these results appear contradictory to the substratum effects of CS-E, they are consistent
with the model that CS-E, present on cell-surface proteoglycans or coated on a
substratum, recruits growth factors to the cell surface, thereby stimulating downstream
A B C
Polyornithine CS-E polysaccharide
CS-E polysaccharide 
+ Chondroitinase ABC
Figure 7.1.  A substratum of CS-E polysaccharide stimulates the outgrowth of hippocampal neurons.
A) Neurons grown on polyornithine-coated coverslips. B) Neurons grown on coverslips coated with
CS-E polysaccharide (16 µg/mL) have longer neurites than control neurons. C) Neurons grown on
coverslips coated with CS-E polysaccharide (16 µg/mL) previously digested with chondroitinase ABC
(10 mU/mL) do not have longer neurites and are similar to control neurons.
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signaling pathways involved in neuronal growth.9, 15  By adding CS-E in solution to
neurons, growth factors are presumably sequestered away from the cell surface, resulting
in neurite inhibition.
Although we observed such striking effects on neuronal growth using CS-E-
enriched polysaccharides, it is possible that there are other sulfation sequences present in
the polysaccaharide that may be contributing to the observed effects.  Therefore, we
proceeded to develop CS glycopolymers that would retain key properties of CS
polysaccharides but would be of a defined, homogeneous sulfation sequence.  Dr. Manish
Rawat developed a new methodology to generate various glycopolymers made up of CS-
E disaccharide, CS-E tetrasaccharide, and unsulfated tetrasaccharide building blocks
(Figure 7.3).20
We evaluated the biological activity of the glycopolymers by measuring their
ability to modulate the outgrowth of hippocampal neurons.  Attempts to evaluate the
activity of the glycopolymers in a substratum-based system proved to be inconclusive;
when the glycopolymers were coated on coverslips neither stimulatory nor inhibitory
effects were observed in this system.  Therefore, we proceeded to evaluate the
A B
Polyornithine CS-E polysaccharide
Figure 7.2. CS-E polysaccharide added in solution inhibits the outgrowth of hippocampal neurons. A)
Neurons grown on polyornithine-coated coverslips. B) Neurons grown on coverslips coated with
polyornithine and treated CS-E polysaccharide (0.1 µg/mL) added in solution have shorter neurites than
control neurons.
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glycopolymers using a solution-based assay where neurons were cultured on
polyornithine coated coverslips and each glycopolymer was added in solution.  Solution
studies were chosen to evaluate the glycopolymers in order to study the importance of
multivalency and macromolecular structure of CS in directing its activity.  Furthermore,
adding the glycopolymers in solution avoids any potential confound multivalency effects
naturally imparted by immobilization of the compounds on surfaces.
Remarkably, CS-E disaccharide glycopolymer 13 mimicked the activity of the
natural polysaccharide (Figure 7.4).  While the isolated CS-E disaccharide was
insufficient for biological activity, incorporation of the disaccharide into a polymeric
framework endowed it with the ability to inhibit neuronal growth.  Moreover, the potency
of the glycopolymers was valence-dependent: polymers with 25 disaccharide units
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Figure 7.3.  Schematic representation of (A) natural CS and (B) CS glycopolymers.  Grey and orange
circles represent the monosaccharide subunits, red circles represent sulfation. C) Structures of CS
glycopolymers
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exhibited moderate activity (40.9 ± 5.5% inhibition), while those with 80 disaccharide
units showed significantly enhanced activity (86.0 ± 5.8% inhibition) at the same
glucuronic acid concentration.  These findings highlight the importance of multivalency
in modulating the activity of CS.  In addition, the unsulfated glycopolymer 14 had little
effect on neurite outgrowth (5.9 ± 5.6% inhibition), confirming earlier observations that
sulfation is a prerequisite for activity16 and highlighting the ability of these
glycopolymers to recapitulate features of natural CS polysaccharides.
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Figure 7.4.  CS-E glycopolymers inhibit the outgrowth of hippocampal neurons. A)
Immunofluorescence images of neurons 48 h after treatment with the indicated compound. B) Statistical
analysis of neurite length.  P values are relative to the untreated neurons. DP, degree of polymerization,
equals the number of repeating subunits.
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We have previously shown that a tetrasaccharide represents a minimum functional
domain for protein recognition and neuronal growth-promoting activity when adhered to
a substratum.9, 14, 16  In this solution-based assay, a monovalent tetrasaccharide at 0.5
µg/mL glucuronic acid concentration had minimal activity (Figure 7.5).  In contrast, CS-
E tetrasaccharide glycopolymer 15 at the same glucuronic acid concentration exhibited
maximal activity, inducing neurite inhibition to the same extent as the natural
polysaccharide (Figure 7.4).
To compare the relative potencies of glycopolymer 15  and the natural
polysaccharide, we measured their inhibition values at various concentrations (Figure
7.6).  We were excited to find that the inhibitory potency of 15 was comparable to that of
the natural polysaccharide (IC50 values of 1.3 ± 0.1 and 1.2 ± 0.1 nM, respectively),
despite considerable changes to the macromolecular structure.  Given the challenges
inherent in the synthesis of large polysaccharides, our approach greatly simplifies the
synthesis of complex glycosaminoglycans, providing synthetically accessible, bioactive
structures of programmable sulfation sequence.  The ability to control the sulfation
pattern within the glycopolymer is significant as it should allow for the generation of CS
A B C
Polyornithine CS-E tetrasaccharide CS-E tetrasaccharide polymer
Figure 7.5.  CS-E tetrasaccharide glycopolymer inhibits hippocampal neurite outgrowth.  A) Untreated
neurons.  B) Neurons treated with CS-E tetrasaccharide (0.5 µg/mL).  C) Neurons treated with CS-E
tetrasaccharide polymer 15.  Monovalent CS-E tetrasaccharide displays no inhibitory activity whereas
CS-E tetra glycopolymer completely inhibits neurite outgrowth.
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type-specific polymers (e.g. CS-E, CS-A, CS-C) with distinct functions.  We anticipate
that these glycopolymers will be powerful tools for further exploring how the
macromolecular structure of CS directs its activity and for manipulating the functions of
CS in vivo.  In all, these studies demonstrate that the CS-E motif is particularly associated
with modulating growth in the brain.  As such, we proceeded to investigate the
mechanism of CS-E stimulated outgrowth and determine which growth factors are
specifically involved and interacting with the CS-E motif.
Molecular dynamic simulations of CS oligosaccharides reveal distinct structures for
each sulfation sequence
With the ability to access well-defined CS sequences, we embarked on systematic
investigations into the role of sulfation.  HS and CS GAGs play critical roles in cell
growth and development by regulating various growth factors, including FGFs,
Hedgehog, Wingless, and semaphorins.3, 18, 21  Peter M. Clark first investigated
computationally whether subtle variations in the sulfation pattern would favor distinct
CS-E Polysaccharide
CS-E Tetra Polymer 15
Concentration, nM
%
 In
hi
bi
tio
n 
of
 N
eu
rit
e O
ut
gr
ow
th
Re
lat
ive
 to
 U
nt
re
at
ed
 N
eu
ro
ns
0
20
40
60
80
100
120
0.1 1 10 100
Figure 7.6.  Comparison of the inhibitory potencies of CS glycopolymer 15 and the natural
polysaccharide at various concentrations.  IC50 values are based on the molar concentration of
compound required to inhibit neurite outgrowth by 50% relative to untreated neurons.
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structural conformations of glycosaminoglycans.  He used the Dreiding force field22
(modified slightly using quantum mechanics) with charges from the charge equilibrium23
(QEq) method and carried out Boltzmann jump simulations24 on tetrasaccharides 8 – 11
to obtain the lowest-energy CS conformations.  These conformations were then used to
perform molecular dynamics simulations24 in explicit water to predict the optimum
conformation in solution.  Interestingly, we found that each CS tetrasaccharide favors a
distinct set of torsion angles and presents a unique electrostatic and van der Waals surface
for interaction with proteins (Figure 7.7).9  Whereas the negatively charged sulfate and
carboxylate groups on CS-C point toward either the top or bottom of the face of the
molecule, as oriented in Figure 7.7, the same charges on CS-A point in several different
directions.  Similarly, although CS-E and CS-R have the same number of sulfate groups,
the relative orientation of these groups along the carbohydrate backbone leads to
distinctly different predicted solution structures.  Whereas the CS-R tetrasaccharide has
the sulfate groups distributed along several faces of the molecule, the CS-E tetrasccharide
presents all four sulfate groups along a single face.  This architecture may position the
sulfate groups to interact with basic amino acid residues characteristic of GAG binding
sites found on proteins.4
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Carbohydrate microarrays reveal distinctive binding of CS sulfation motifs to
neuronal growth factors
To explore the functional consequences of sulfation on growth factor binding, we
generated carbohydrate microarrays using the CS tetrasaccharides. Carbohydrate
microarrays have proven to be powerful tools for investigating the interactions of various
glycans with proteins, viruses, and bacteria.25 -- 27  However they have not been
extensively exploited for detailed structure-function analyses of GAGs, which pose the
unique challenge of presenting carbohydrate structures closely related in stereochemistry
and sulfation sequence.  Dr. Sarah E. Tully developed and validated the microarray
methodology and proceeded to investigate the effects of sulfation on the binding of CS to
the growth factor midkine (Figure 7.8).9  Midkine participates in the development and
Figure 7.7.  Each sulfation pattern exhibits a distinct structural conformation.  A) Average structures
from molecular dynamics simulations of the CS tetrasaccharides in water. B) Chemical structures of the
CS tetrasaccharides.  The sulfation pattern influences the structure of CS, allowing it to present distinct
electrosatic and van der Waals surfaces to proteins.  The CS ball-and-stick figures were created in
PyMol and the electrostatic maps were created using GRASP.
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repair of neural and other tissues and binds with nanomolar affinity to heterogeneous
polysaccharides enriched in the CS-E motif.28, 29  We observed selective binding of
midkine to the CS-E tetrasaccharide at CS concentrations within the physiological
range.30  Notably, the midkine interaction was highly sensitive to the position of the
sulfate groups along the carbohydrate backbone (Figure 7.8B).  The interaction of
midkine with CS-A and CS-C was significantly weaker than that with CS-E.  Midkine
did not interact as strongly with CS-R as with CS-E, indicating that the midkine-CS
association requires a specific arrangement of sulfate groups and is not dictated by
nonspecific, electrostatic interactions.
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Figure 7.8.  A specific sulfation pattern promotes the interaction of CS with neuronal growth factors.
A) Overall scheme to detect CS-protein interactions using carbohydrate microarrays. The CS-E
tetrasaccharide interacts with the growth factors midkine B) and BDNF C).  D) None of the CS
tetrasaccharides interact with FGF-1.  *P < 0.0001, relative to CS-E tetrasaccharide for a given
concentration. **P ≤ 0.001, relative to CS-E tetrasaccharide for a given concentration.
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Access to defined sulfation sequences coupled with microarray technologies
provides a powerful, rapid means to identify novel GAG-protein interactions and to gain
insight into the functions of specific sulfation sequences.  In addition to midkine, we
discovered that brain-derived neurotrophic factor (BDNF) selectively binds to the CS-E
sulfation sequence.9  The neurotrophin BDNF controls many aspects of mammalian
nervous system development and contributes to synaptic plasticity, neurotransmission
and neurodegenerative disease.31  We found that BDNF exhibited a 20-fold preference for
the CS-E motif relative to CS-C, CS-A, and CS-R at 5 µM CS concentration, which
approximates the estimated concentration of CS-E present in physiological samples
(Figure 7.8C).29, 30, 32 As a control, we demonstrated that none of the tetrasaccharides
interacted strongly with FGF-1 (Figure 7.8D), consistent with studies indicating that
FGF-1 is regulated by HS but not CS GAGs.19, 21
Midkine and BDNF signaling pathways are activated by CS-E interaction
The ability of the CS-E sulfation sequence to interact with growth factors and
modulate neuronal growth suggests that CS may recruit specific growth factors to the cell
surface, thereby activating downstream signaling pathways.  To investigate this potential
mechanism, we cultured hippocampal neurons on a CS-E tetrasaccharide or polyornithine
substratum in the presence or absence of antibodies selective for midkine or BDNF.33, 34
The antibodies were expected to block the interaction of the endogenous growth factors
with the CS-E substratum and thereby abolish the neuritogenic effects.  The effective
concentration of each antibody was first determined by treating neurons grown on
polyornithine with varying antibody concentrations from 0.5 µg/mL to 20 µg/mL.  Only
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those concentrations of antibodies that did not affect neuronal growth were then used in
the presence of the CS-E tetrasaccharide.  The effective concentration of each antibody
was determined to be the highest concentration of antibody that elicited the greatest effect
in the presence of the tetrasaccharide without eliciting any effect in untreated neurons.
Antibodies to midkine or BDNF had no effect on neurite outgrowth in the absence of the
tetrasaccharide (Figure 7.9A and 7.10).9  Importantly, addition of either antibody blocked
the neurite outgrowth induced by CS-E.  In contrast, neither a control antibody selective
for FGF-1 nor class-matched control antibodies were able to abolish the growth-
promoting effects of CS-E (Figure 7.9A and 7.10).
To further confirm the activation of midkine and BDNF signaling pathways by
CS-E, we used antibodies that recognize the extracellular domains of the cell surface
receptors protein tyrosine phosphatase ζ (PTPζ) and tyrosine kinase B receptor (TrkB).
Figure 7.9.  The CS-E sulfation motif stimulates neuronal growth through activation of the midkine-
PTPζ and BDNF-TrkB signaling pathways.  A) Antibodies (Ab) selective for midkine (4 µg/mL) or
BDNF (1 µg/mL), but not FGF-1 (4 µg/mL), block the neurite outgrowth induced by CS-E.  B)
Antibodies against the receptors PTPζ (2 µg/mL) or TrkB (1 µg/mL), but not TrkA (4 µg/mL), abolish
the growth-promoting effects of CS-E.  *P < 0.0001, relative to the no CS-E, no antibody control.
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Binding of midkine and BDNF to PTPζ and TrkB, respectively, has been shown to
promote neuronal outgrowth and survival in various systems by activating intracellular
pathways such as the mitogen-associated protein kinase (MAPK) and
phosphatidylinositol 3-kinase (PI3-K) pathways.28, 31  Notably, antibodies against either
PTPζ or TrkB blocked the neuritogenic activity of CS-E (Figure 7.9B and 7.10).9  In
contrast, neither antibody alone had an effect on neurite outgrowth in the absence of CS-
E.  To demonstrate the specificity of the effects, we showed that function-blocking TrkA
and class-matched control antibodies do not influence CS-E mediated neurite outgrowth
(Figure 7.9B and 7.10).  These results indicate that the CS-E sulfation motif stimulates
neuronal growth in vitro through selective activation of midkine-PTPζ and BDNF-TrkB
signaling pathways.
Figure 7.10. Function-blocking antibodies against BDNF and TrkB, but not class-matched control
antibodies, disrupt the neuritogenic activity of CS-E. A) The BDNF (10 µg/mL), TrkB (0.5 µg/mL), and
TrkA (0.5 µg/mL) antibodies have been shown previously to block endogenous neurotrophin and
receptor function. Chicken IgY (10 µg/mL) was the control for the BDNF antibody.  B) Goat IgG (4
µg/mL) was the control for the midkine, TrkB, and TrkA antibodies. C) Rabbit IgG (2 µg/mL) was the
control for the BDNF, PTPζ, and function-blocking TrkA antibodies; and mouse IgG (4 µg/mL) was
the control for the FGF-1 and function-blocking TrkB antibodies. *P < 0.0001, relative to the no CS-E,
no antibody control
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Discussion
The structural diversity of GAGs in vivo has led to the hypothesis that specific
sulfated structures may modulate the binding and activity of growth factors.  However,
the complexity and heterogeneity of GAGs has hindered efforts to establish whether
growth factors recognize unique sulfation sequences.  The overall goal of our research
project was to develop a systematic method to investigate the structure-activity
relationships of CS carbohydrates.  Toward this end, we devised a chemical approach
where CS oligosaccharides of defined length and sulfation pattern were synthesized to
evaluate the biological activities associated with distinct sulfation sequences.9, 16
Evaluation of the synthesized molecules revealed that the CS-E sulfation motif was
uniquely capable of interacting with neuron growth factors and stimulated the outgrowth
of various neuron types.  Moreover, we determined that CS-E-mediated stimulation of
neurite outgrowth was facilitated by activation of midkine/PTPζ and BDNF/TrkB
pathways.
Understanding the many roles of GAGs will require new approaches and reagents
to probe and manipulate their structures.  We have shown that synthetic chemical
approaches are particularly valuable in this regard, enabling the identification of
biologically active sulfation motifs, systematic structure-function studies, and the
analysis of glycosaminoglycan-protein interactions.  While GAGs cannot yet be
assembled with the same ease as nucleic acids or proteins, rapid advances in their
synthesis and characterization are enabling the first molecular-level investigations of this
important class of biopolymers.  We anticipate that our approach to systematically
explore the role of sulfation sequences will open numerous opportunities for structural
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and biophysical studies, as well as facilitate exploration of the roles of GAGs across
various proteins and biological contexts.
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Experimental Procedures for Chapter 7
Buffers and Reagents:
Chemicals and molecular biology reagents were purchased from Fisher (Fairlawn, NJ)
unless stated otherwise.  Cell culture media was purchased from Gibco BRL (Grand
Island, NY).  German glass coverslips were purchased from Carolina Biologicals
(Burlington, NC).
Neuronal Cultures:
Hippocampal neuronal cultures were prepared from embryonic rats as described in
Chapter 2.
Preparation of Coverslips:
Glass coverslips were coated as described in Chapter 6.
Calibration of CS Molecules:
The relative concentrations of the CS-E polysaccharide and CS-E oligosaccharides were
calibrated to one another using the carbazole assay as described in Chapter 6.
Treatment of Hippocampal Neurons with the CS-E Polysaccharide and CS
Glycopolymers:
Hippocampal neuronal cultures were incubated in 5% CO2 at 37 °C for 24 h.  The media
was then removed, and a 1.25 µL solution of CS-E polysaccharide (Seikagaku; ~ 60% of
the polysaccharide is estimated to contain the CS-E motif) or glycopolymer in 3.5 M aq.
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NaCl was added to supplemented Neurobasal medium (498.75 µL) on each coverslip.  A
fixed uronic acid concentration of 0.5 µg/mL was used in each case to compare the
effects of multivalency.  This concentration corresponded to molar concentrations of 14.3
nM for the natural CS-E polysaccharide and 53 nM, 33.2 nM, 2.9 nM, and 16.6 nM for
glycopolymer 13 with degree of polymerization (DP) values of 25, 40, 58, and 80,
respectively.  The molar concentrations of glycopolymers 14 and 15 were 43.2 nM and
12.1 nM, respectively.  Importantly, no cellular toxicity was observed at the
concentrations used for each compound, as demonstrated by adherence of the cells to the
coverslip and healthy cellular morphology.  The cultures were incubated for an additional
24 h in 5% CO2 at 37 °C and analyzed by immunocytochemistry.
Determining the Relative Potencies of the Natural Polysaccharide and Glycopolymer 15:
Hippocampal neurons were grown for 24 h before medium was replaced with fresh
supplemented Neurobasal medium.  Compounds were added at various uronic acid
concentrations ranging from 0.01 to 0.5 µg/mL.  Neurons were incubated with the
compounds for 24 h and then analyzed for neuronal outgrowth as described.  To
determine the IC50 values, the concentrations of the CS-E polysaccharide were calculated
based on an average molecular weight of 70,000 g/mol, as provided by the manufacturer.
For glycopolymer 15, a molecular weight of 84,096 g/mol, as determined by GPC, was
used.  The concentration values were plotted against the % inhibition of neurite
outgrowth relative to untreated neurons, and the IC50 values represent molar
concentrations of compound needed for 50% inhibition of neurite outgrowth.  IC50 values
of 1.2 ± 0.1 nM and 1.3 ± 0.1 nM were determined for the natural polysaccharide and
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glycopolymer 15, respectively (1.2 ± 0.1 nM and 1.6 ± 0.1 nM if calculated based on the
saccharide content of each molecule).
Antibody Treatment of Neuronal Cultures:
For the antibody treatments, we cultured hippocampal neurons on a substratum of poly-
DL-ornithine in the presence or absence of CS-E tetrasaccharide (100 µL of a 500 µg/mL
solution).  After 24 h, we added to the medium (final volume of 500 µL) antibodies
selective for midkine (Santa Cruz; goat IgG raised against the C terminus of the protein;
final concentration of 4 µg/mL), BDNF (Santa Cruz; rabbit IgG raised against residues
130 – 247; final concentration of 1 µg/mL; and Promega; chicken IgY raised against
human recombinant protein; final concentration of 10 µg/mL), FGF-1 (R & D Systems;
mouse IgG raised against recombinant human protein; final concentration of 4 µg/mL),
PTPζ (Santa Cruz; rabbit IgG raised against extracellular domain residues 141 – 440;
final concentration of 2 µg/mL), TrkB (Santa Cruz; goat IgG raised against the
extracellular domain; final concentration of 1 µg/mL; and BD Transduction Laboratories;
mouse IgG raised against extracellular residues 156 – 322; final concentration of 0.5
µg/mL), or TrkA (Santa Cruz; goat IgG raised against the extracellular domain; final
concentration of 4 µg/mL; and Abcam; rabbit IgG raised against extracellular residues 1
– 416; final concentration of 0.5 µg/mL).  As controls for specificity, we used the
corresponding class-matched antibodies (goat IgG, Pierce; rabbit IgG, Pierce; mouse IgG,
Pierce; or chicken IgY, Promega) for comparison.  The class-matched controls for the
midkine, TrkB, and TrkA antibodies were the goat IgG (4 µg/mL), mouse IgG (4
µg/mL), and rabbit IgG (2 µg/mL).  The class-matched controls for the BDNF and PTPζ
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antibodies were the rabbit IgG and chicken IgY, used at 2 µg/mL and 10 µg/mL,
respectively.  The class-matched control for the FGF-1 antibody was the mouse IgG, used
at 4 µg/mL.  We cultured neurons for an additional 24 h before immunostaining them
with an antibody to tubulin (Sigma; 1:500) and analyzing them by microscopy.
Immunocytochemistry of Neuronal Cultures:
After 48 h in culture, neurons were treated for immunostaining as described in Chapter 6.
Confocal Laser Microscopy and Morphometric Analysis:
Cells were evaluated by confocal microscopy and quantified for neurite length as
described in Chapter 6.  Additionally, cells were imaged on a Nikon Eclipse TE2000-S
inverted microscope.  The images were captured with MetaMorph 6.1 software using a
40x plan fluor oil objective.
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